The Carcinogenic Hydrocarbons: Chemical Constitution and Carcinogenic Activity by Badger, G. M.
BRITISH JOURNAL OF CANCER
VOL. II DECEMBER, 1948 NO. 4
THE CARCINOGENIC HYDROCARBONS: CHEMICAL
CONSTITUTION AND CARCINOGENIC ACTIVITY.
G. M. BADGER.*
From the Chemistry Department, University of Glasgow.
Received for publication August 20, 1948.
IT is less than twenty years since it was first clearly demonstrated that certain
pure polycyclic aromatic hydrocarbons have the property of inducing cancerous
growths when applied, in solution, to the skin of animals. During the inter-
vening years a very considerable number of synthetic cancer-producing sub-
stances has been prepared, and a very potent cancer-producing agent present in
coal tar has been isolated in a pure state. For reviews see Cook, Haslewood,
Hewett, Hieger, Kennaway, and Mayneord (1937); Cook and Kennaway (1938
and 1940); Fieser (1937 and 1938); Cook (1939 and 1943); Haddow (1947);
Haddow and Kon (1947); Fieser, Fieser, Hershberg, Newman, Seligman and
Shear (1937).
Apart from the polycyclic aromatic hydrocarbons, several other types of
organic and inorganic compounds have the property of initiating cancers. The
most important are: various azo compounds; certain amino stilbenes, and
compounds related to 2-aminofluorene. Certain types of tumour have also been
induced with oestrogenic hormones, with carbon tetrachloride, with ethyl car-
bamate (" urethane "), and by other substances. Hartwell (1941) has published
a " Survey of compounds which have been tested for carcinogenic activity."
This comprehensive work covers the literature through 1939, and includes data
on 696 different chemical compounds, of which 169 were reported to be carcino-
genic.
It is probably true to say that the first stage in the investigation of the car-
cinogenic substances is now over, and that future work must be directed towards
the study of (a) the fate of such substances in the animal body, (b) the relation-
ship, if any, between the known carcinogens and " spontaneous " cancer in
humans, and (c) the mode of action of the carcinogens. In connection with the
latter, the study of the relationship between chemical constitution and carcino-
genic activity is of obvious importance. It was made clear from the early work
that although relatively small changes in the structure ofa carcinogen frequentlv
converted it into an inactive derivative, major alterations could sometimes be
carried out with but little change in activity. For this reason there was, at first,
little or no attempt to produce an all-embracing theory. In recent years, how-
ever, there have been many attempts to find the relationship between chemical
constitution and carcinogenic activity, and it appeared opportune to examine
the available data on this subject. The present review is confined to the poly-
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cyclic aromatic compounds, their heterocyclic analogues, and other closely
related substances.
HISTORICAL.
The first detailed investigations into the nature of the carcinogenic factor in
coal tar were made by Bloch and Dreifuss (1921), who found that it is concen-
trated in the high boiling fractions, that it is free from nitrogen, arsenic and
sulphur, and that it forms a stable picrate with picric acid. These results were
extended by Kennaway (1924a, b, c; 1925) and Kennaway and Sampson (1928),
who prepared artificial tars both from complex organic materials, such as skin,
hair, yeast andcholesterol, and from hydrocarbons, such as acetylene andisoprene.
The latter tars were prepared by passing the hydrocarbon, with hydrogen, through
a strongly heated tube. All this work indicated that- the carcinogenic agent in
tar is a complex aromatic hydrocarbon. Many of the known constituents of
coal tar were accordingly tested by application of a solution of the pure hydro-
carbon to the skin of mice; but all the compounds tested were found to be
inactive.
The first clue as to the nature of the carcinogenic factor was provided in 1927
by Mayneord, who observed that the same characteristic fluorescence bands were
to be found in various carcinogenic tars. He found also that the complex mixture
obtained by Schroeter by the action of aluminium chloride on tetrahydronaph-
thalene, which had no connection with any form of tar, and was carcinogenic
(Kennaway, 1930), showed this same spectrum. Details of the fluorescence
spectrum of several tar fractions and mineral oils, and of many pure compounds,'
were given by Hieger (1930). The fluorescence bands of the carcinogenic mix-
tures were found to be at 4000, 4180 and 4400A, and Hieger observed that pure
1:2-benzanthracene has a very similar spectrum, although the bands are shifted
towards shorter wave lengths.
In 1929 Clar described the synthesis, by simple reactions, of a number of
complex'hydrocarbons related to 1:2-benzanthracene. These compounds were
also prepared, in London, and submitted to biological test. Other benzanthra-
cene derivatives were prepared by Cook in an attempt to reproduce exactly the
fluorescence spectrum of the carcinogenic tars. As a result of this work 1:2:5:6-
dibenzanthracene (I), 3'-methyl-1:2:5:6-dibenzanthracene and 6-isopropyl-1:2-
benzanthracene (II) were found to be cancer-producing (Cook, Hieger, Kennaway
and Mayneord, 1932; Clar, 1929; Cook, 1931, 1932a, 1932b; Fieser and Dietz,
1929).
6 II 21 CH 21 j6 CR3
\/ ~~~~~~CH3
I. .II.
Several other related compounds were also found to be cancer-producing,
but none ofthese synthetic compounds was identical with the carcinogenic factor
present in coal tar. All were found to give fluorescence bands more or less dis-
placed from those observed with the carcinogenic tars. A strongly carcinogenic
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crystalline fraction was separated from two tons of pitch by a lengthy series of
purification processes, guided by a study of the fluorescence spectrum of each
fraction (Hieger, 1937). From this fraction a compound was isolated (Cook,
Hewett and Hieger, 1933), which was found to be identical with the new com-
pound 3:4-benzpyrene (III) synthesized by Cook and Hewett. (In accordance
with the " Patterson " system this compound was designated 1:2-benzpyrene in
the original paper, but was later renamed 3:4-benzpyrene to conform to the older
"Richter " system ofnumbering the pyrene molecule. Both systems ofnumber-
ing pyrene are in common use at the present time. The Patterson system is
used by both Chemical Abstracts and British Abstracts, but the older Richter
system still appears to be the method of choice for most original journals.) The
synthesis was achievedby condensingpyrenewith succinic anhydride, reducing the
10
19
3 ' 2 8 1 I7
III. IV.
resulting keto acid to y-l-pyrenylbutyric acid, cyclizing, reducing the resulting
ketone, and finally, dehydrogenating. This method did not establish the structure
rigidly, so the isomeric 1:2-benzyprene (designated 4:5-benzpyrene in the original
paper) was also synthesized by the same series of reactions from s-hexahydro-.
pyrene. This latter synthesis can only lead to 1:2-benzpyrene, and as there are
only two possible benzpyrenes, the structure of both products was confirmed.
The identity of the synthetic 3:4-benzypyrene and the material isolated from
coal tar was confirmed by mixed melting-point, by comparison ofthe fluorescence
spectra, and it was also shownthatbothspecimenswere equallypotentcarcinogens.
The amount of 3:4-benzpyrene in coal tar has been variously estimated.
According to Kruber (1940), 132 kg. of ordinary coal tar pitch contains 1 g. ; but
Winterstein (1936) obtained 2 5 g. of almost pure 3:4-benzpyrene from 50 kg. of
tar which contained 3 kg. of material boiling above 4500. According to Beren-
blum and Schoental (1943a), who used a spectrographic method of estimation,
coal tar may contain as much as 15 per cent of 3:4-benzpyrene, and a simple
method ofextraction, by which Berenblum (1945a) isolated 75 mg. ofalmost pure
material from 10 g. of crude coal tar distillate (b.p. 200-240o/0.1 mm.), has
recently been devised.
Recent work by Berenblum and Schoental (1947) has shown conclusively that
coal tar contains carcinogens in addition to 3:4-benzpyrene. One of these is
more potent to the rabbit's skin than to that of the mouse, and this evidently
accounts for the fact that tumours in rabbits are more readily produced with
coal tar than with 3:4-benzpyrene. These additional carcinogenic factors present
in coal tar have not yet been isolated in a pure state, although there is little
doubt that they also belong to the class ofpolycyclic aromatic hydrocarbons. In
this connection it should be emphasized that the isolation of 3:4-benzpyrene was
very greatly facilitated by the fact that this compound possesses a characteristic
fluorescence which is many times more intense than that of the other compounds
from which it has to be separated (Berenblum and Schoental, 1946a).
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Following the discovery of the synthetic carcinogens, and of benzpyrene,
attention was concentrated on the possibility that chemical carcinogens may play
a part in the initiation of " spontaneous " human cancers, other than those
known as " occupational " cancers. Kennaway and Cook (1932) suggested that
carcinogenic polycyclic aromatic hydrocarbons may arise from certain sterols by
some abnormal mechanism. Indeed, Cook (1933b) predicted that 20-methyl-
cholanthrene (VIII), prepared by a series of reactions from deoxycholic acid (V)
(Wieland and Dane,.1933; Cook and Haslewood, 1933, 1934, 1935) would prove
to be carcinogenic before tests had been carried out. This prediction was sub-
stantiated, and methylcholanthrene was found to be a very potent cancer-pro-
ducing substance (Barry, Cook, Haslewood, Hewett, Hieger andKennaway, 1935).
Methylcholanthrene has also been prepared from cholic acid, and from choles-
terol. It was prepared synthetically by Fieser and Seligman (1935).
CCH2-C02H / \
CR2 ~~~~/CH,a CH2 /C X
\CH\>
OH37 __
V.
(Deoxycholic acid.)
CH2-CO2H
/ote 0 Two stages CR2
VI.
(12-Ketocholanic acid.)
Dehydrogenation
CH3
VII.
(Dehydronorcholene.)
2
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CH3 120
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VIII.
(20-Methylcholanthrene.)
As it was first prepared from sterols, methylcholanthrene retains the number-
ing of the sterol ring system. It is clear, however, that it is most conveniently
considered as a 1:2-benzanthracene derivative (A) substituted in positions 6, 5,
and 10. In Chemical Ab8tracts methylcholanthrene is numbered as (B), and this
method of numbering has been used in some original papers.
(A)
2 1
(B)
In describing the biological results with methylcholanthrene, Barry et al.
(1935) concluded.: " Methylcholanthrene thus establishes a clear connecting
Heat
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link between the carcinogenic hydrocarbons and the sterols and bile acids, and
it is of great interest that the changes by which it is obtained from deoxycholic
acid are all reactions ofthe type which are known to occur normally in the animal
body, although there is no evidence that this particular sequence of changes
involved in the formation of methylcholanthrene does actually occur in nature."
The possibility that chemical compounds of this type may play a part in the
initiation of " spontaneous " human cancers remains a speculation, and a dis-
cussion of the evidence both for and against such an hypothesis is outside the
scope of the present review. Carcinogenic factors, of unknown structure, do
occur in human tissues, and this line of research is being actively pursued by
several workers. For a review see Hieger (1947).
The discovery of methylcholanthrene further stimulated synthetic work,
especially among di- and poly-substituted benzanthracenes. Other ring systems
have also been investigated, and it is now clear that carcinogenic activity
may be found in derivatives of many different ring systems, including many
heterocyclic systems.
RELATIVE POTENCY OF CARCINOGENS.
Two techniques have been most extensively used for testing polycyclic aro-
matic hydrocarbons for carcinogenic activity. The first of these involves the
application of the hydrocarbon, in 0 3 per cent solution in benzene, to the inter-
scapular region of stock mice twice weekly (Cook, Hieger, Kennaway and May-
neord, 1932). Other solvents, including tetralin, xylene and acetone, have been
used, and more dilute solutions are sometimes advantageous (Bachmann, Kenna-
way and Kennaway, 1938). Further, pure strain mice are sometimes preferred
to stock mice. This method of test results, after a more or less prolonged latent
period, in the appearance ofpapillomas and epitheliomas.
The second method, which gives rise to sarcomas, involves the injection of
the carcinogen subcutaneously, or intraperitoneally. The crystalline material is
sometimes injected in the form of a pellet of about 5 mg., but often, a solution
of the hydrocarbon in lard, cholesterol, sesame oil, tricaprylin, or other such
solvent, is injected. The quantity administered has varied from author to
author; and more than one injection has often been given, especially in the
case of the less active compounds. Both stock mice and mice of pure strains
have been used (Burrows, Hieger and Kennaway, 1932; Burrows, 1932; Shear,
1936a).
Both methods of administration sometimes result in the appearance of a
number of tumours, e.g. of the liver, lungs, etc., not at the site of application.
Such tumours are normally omitted from discussions of the relative potency of
carcinogens ofthe polycyclic aromatic type-mainly because the data are insuffi-
cient for their correct appraisal (Badger, Cook, Hewett, Kennaway, Kennaway,
Martin and Robinson, 1940). In the case of the carcinogenic azo compounds,
and with certain other classes of compound not discussed in this review, tumours
do not normally appear at the site of application, and the remote tumours are
the only means of comparison of carcinogenic potency.
All carcinogens do not have the same potency. Tumours appear in treated
animals (usually mice) only after a latent period, which varies from about a month
or two for very active compounds, to nearly two years for the very feebly active
compounds. Very active substances also induce tumours in a high percentage
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ofmice, while substances ofslight activity produce tumours in only a few animals
after a prolonged latent period.
Many attempts have been made to devise a system suitable for the accurate
comparison of the potency of carcinogens. In many ways the best method is
that due to Iball (1939), who introduced a carcinogenic index, defined by the
relationship:
Percentage number of tumours Carcinogenic index Average latent period in days
The percentage'number of tumours was obtained from the number of animals
bearing tumours, and thenumber ofanimals alive when the first tumour appeared.
This method has the advantage that it eliminates animals which die too early to
be affected by the compound under test. In this method of calculating the
relative potency of carcinogens (and also in most other methods which have
been suggested) papillomas are given the same weight as epitheliomas.
Fieser (1938) has also called attention to the importance of the latent period.
He critically examined the data for the more important carcinogens, and
attempted to compare the relative potencies by comparing average induction
periods, weighted according to the number of tumours produced in any given
experiment.
In a more recent study of the problem Berenblum (1945b) has suggested a
system of carcinogenic grades, from XII to I, the grade XII being applied to
compounds of very pronounced carcinogenic activity, and the grade I being
applied to compounds with only trace activity. This system is also based on the
latent period of carcinogenesis, and the carcinogenic grade is obtained from a
diagram in which the grade (I to XII) is plotted against the latent period in
weeks. The latter is on a logarithmic scale in order to eliminate the prominence
which would otherwise be given to compounds of low potency.
Interesting discussions and information relative to the determination of car-
cinogenic potency are also to be found in papers by Shimkin (1940), Bryan and
Shimkin (1940), and by Lea (1945). A comprehensive paper on the statistical
treatment of measurements of the carcinogenic properties of tars and' mineral
oils has been published by Irwin and Goodman (1946).
None of these methods has been used extensively by other authors, and in
only a very few papers has sufficient data been published for any of them to be
used with reasonable accuracy. Iball's carcinogenic index has, however, been
used in a few cases (Shimkin and Anidervont, 1940; Badger, Elson, Haddow,
Hewett and Robinson, 1942; Lacassagne, Buu-Hoi, Lecocq, and Rudali, 1946).
Berenblum's carcinogenic grading is somewhat simpler, but in the opinion of the
present author any attempt to compare the relative potency of different hydro-
carbons by the use oftwelve grades is apt to give a greater semblance ofaccuracy
than is justified, especially when it is desired to compare the results from different
laboratories, possibly using different animal strains and different techniques. All
attempts to study the relationship between chemical constitution and biological
activity must be limited by the inaccuracies inherent in all biological assays, and
specific reference to the extreme difficulties in testing carcinogenic compounds
has been made by Hartwell.(1941, p. 9).
For these reasons the grading ofpotency in the present paper has been made
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as simple as possible. The potency of the compounds to both epithelial cells
and to cells of connective tissue have both been classified as follows:
+±+ + signifies very marked carcinogenic activity.
+++ ,, marked carcinogenic activity.
+ ,, moderate carcinogenic activity.
+ ,, - slight carcinogenic activity.
0 ,, inactive.
The working of the system in practice may be observed from Table I, in which
the carcinogenic index of Iball, the carcinogenic grade of Berenblum, and the
system adopted in the present paper are compared for 10 well-known compounds
which have been tested by application to the skin of mice.
TABLE I.-Relative Potency of Carcinogens to the Skin of Mlfice; Comparison of
Different Systems of Grading.
Average
Compouxnd. Per cent latent Iball's Berenblum's This paper. tumours. period index, grade.
(days).
9:10-Dimethyl-1:2-benz- 65 . 43 . 151 . X .++++
anthracene
20-Methylcholanthrene . 88 5 . 109 . 80 . VIII . +± ± +
3:4-Benzpyrene . . 89'5 . 119 . 75 . VIII .++++
2-Methyl-3:4-benz-
phenanthrene 75 . 155 . 48 . VII . +++
10-Methyl-1:2-benz-
anthracene 66-5 . 147 . 45 . VI ? . +++
5-Methyl-1:2-benz-
anthracene 8795 . 317 . 28 . V . ++
1:2:5:6-Dibenzanthracene . 63 . 239 . 26 . VI . ++
3:4-Benzphenanthrene . 67 . 387 . 17 . V . +
1:2:5:6-Dibenzacridine . 24 . 350 . 7 . 4 . +
3:4:5:6-Dibenzacridine 39 3 . 357 . 11 . IV . +
This method of grading which is adopted has the very great advantage of
simplicity. Evenso, itisdifficult, in some cases, to be certain ofthe mostaccurate
grading, as the published data are often so meagre. :Furthermore, in view of
the difficulties of biological assay, the probable or expected error in grading is at
least one + symbol.
THE STRUCTURE OF THE CARCINOGENIC COMPOUNDS.
(a) Polycyclic aromatic hydrocarbons, and the effect of methyl groups.
As has already been pointed ouit, the resemblance between the fluorescence
spectra of the carcinogenic tars and that given by pure 1:2-benzanthracene (iX)
provided the first clue as to the nature of the active principle. It also provided
the starting-point for the synthetic approach, which led to the testing of 1:2:5:6-
dibenzanthracene, to the synthesis and testing of 6-isopropyl-1:2-benzanthracene,
and of other compounds. Since then many,of the homologues of the tricyclic,
the tetracyclic, the pentacyclic and a few hexacyclic aromatic hydrocarbons have
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been tested, and examples ofeach class of compound have been shown to possess
cancer-producing activity. In this and in the subsequent sections references
to tests for carcinogenic activity are to be found in the tables. Only in the cases
of compounds not listed in tables have references to the literature been appended
in the text.
Anthracene, phenanthrene and a fewsimple derivatives were tested in the very
early experiments (Hartwell, 1941) and found to be inactive. It is only recently
that two simple derivatives have been shown to possess slight but definite car-
cinogenic activity to the skin of mice. These active homologues are 1:2:3:4-tetra-
methylphenanthrene, and 9:10-dimethylanthracene, and they are the simplest
examples of carcinogen yet found among the polycyclic aromatic hydrocarbons
(Badger, Cook, Hewett, Kennaway, Kennaway and Martin, 1942; Kennaway,
Kennaway and Warren, 1942).
There are six possible tetracyclic aromatic hydrocarbons composed entirely
of aromatic rings, and each has been investigated. Only 3:4-benzphenanthrene
(X) has been shown to possess significant, if slight, activity. Tumours have
occassionally been attributed to chrysene (XI), but these are probably due to
impurities almost invariably associated with this hydrocarbon. 1:2-Benzan-
thracene (IX) has also given one or two tumours in very extensive tests, but it is
doubtful if these are significant. Triphenylene (XII), pyrene (XIII) and naph-
thacene (XIV) appear to be inactive.
2' 6 2 3
5 1' 3' \7 1 /\4
IX. X. XI.
1:2-Benzanthracene. 3:4:-Benzphenanthrene. Chrysene.
//\ ~~3/\5
9 1! 11 1 III
3\\,X3 I4' 7 8\\ <// 2// ~~32 9\7
5 0 1 10 8
4~~~~~~~~~~~~~~~~~~~ 4
XII. XIII. XIV.
Triphenylene. Pyrene. Naphthacene.
All the twelve possible monomethyl derivatives of 1:2-benzanthracene have
been prepared and tested, many of them both by application to the skin and by
subcultaneous injection. There is no doubt that the introduction of a methyl
group into one of the " favourable " positions has a very pronoulnced effect, and
may give rise to a very potent cancer-producing substance. The most active
derivatives are those in which a methyl group-has been introduced into positions
10-, 9-, or 5-. The introduction of a methyl group into positions 6-, 7-, 8-, 3- or
4- serves to produce a moderately to very slightly active substance, but methyl
groups in the angular ring, that is in positions 1'-, 2'-, 3'- or 4'-, do not seem to
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have this effect. 4'-Methyl-l: 2-benzanthracene may have trace activity, but
I'-methyl-, 2'-methyl-, and 3'-methyl-1:2-benzanthracenes appear to be entirely
inactive (Table II).
The effect of additional methyl groups is, in general, to give rise to more
potent compounds. As a general rule, dimethylbenzanthracenes are more potent
than either of the monomethyl derivatives to which they are related. 9:10-Di-
methyl-1:2-benzanthracene is especially active to the skin of mice, and produces
many tumours withina remarkably short latent period. 5:9-Dimethyl- and 5:10-
dimethyl-1:2-benzanthracenes are also remarkably active cancer-producing sub-
stances, and 5:6-dimethyl-1:2-benzanthracene is also more active than either of
the monomethyl derivatives to which it is related. On the other hand, there
appear to be some exceptions to this generalization. 5:8-Dimethyl- and 3:9-
dimethyl-1:2-benzanthracenes appear to be inactive, at least when administered
by injection. Furthermore, it is also of some interest that all the dimethyl-
benzanthracenes having a methyl group in the angular ring are entirely inactive.
A few polysubstituted benzanthracenes have also been examined. 5:9:10-
Trimethyl- and 6:9:10-trimethyl-1:2-benzanthracenes are extremely active car-
cinogens, as might be expected. On the other hand, 5:6:9:10-tetramethyl-1:2-
benzanthracene appears to be somewhat less active than either of the trimethyl,
meso-substituted benzanthracenes to which it is related. It is possible that there
is an optimum number of methyl groups which can b6 introduced and which
lead to an increase in potency. This possibility, though widely accepted, has not
been extensively investigated.
The cholanthrenes, and related compounds, are most conveniently considered
as substituted benzanthracenes, although the sterol numbering often used tends
to confuse the relationship. Cholanthrene, 20-methylcholanthrene, 22-methyl-
and 23-methylcholanthrene have been prepared and tested. They may be con-
sidered as benzanthracenes substituted in positions 10-, 5- and one other position.
All were found to be very active, but there is little doubt that 20-methylcholan-
threne is the most active, then cholanthrene, then 22-methylcholanthrene, and
then least active, 23-methylcholanthrene. Law and Lewisohn (1941) have also
examined these compounds by subcutaneous injection in " strain C " mice, and
observed that 20-methylcholanthrene and 22-methylcholanthrene are signifi-
cantly more potent in inducing lung tumours than the parent hydrocarbon,
cholanthrene, and that 23-methylcholanthrene is significantly less potent than
cholanthrene.
In view ofthe specialinterest of methylcholanthrene many related compounds
were tested. One line of approach was to vary the positions of attachment of
the dimethylene bridge. Acenaphthanthracene (4':3-ace-1:2-benzanthracene) is
only slightly active, 8:9-ace-1:2-benzanthracene is moderately active, 4:10-ace-
1:2-benzanthracene is a potent carcinogen, but cholanthrene (5:10-ace-1:2-
benzanthracene) is the most potent. These results again indicate the pre-
eminence of positions 5- and 10- for the development of carcinogenic activity.
It is surprising that 7-methyl-8:9-ace-1:2-benzanthracene is inactive.
It was at first thought that the dimethylene bridge might have some special
significance for the development of carcinogenic activity, but this has since been
disproved. 5:10-Dimethyl-1:2-benzanthracene, and cholanthrene are. approxi-
mately equallypotent; similarly, 4:10-ace-1:2-benzanthracene and 4:10-dimethyl-
1:2-benzanthracene are moderately, and about equally, potent. The dimethylene
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bridge present in these compounds therefore appears to be approximately equi-
valent to two methyl groups in the same positions.
There are six possible monomethyl derivatives of 3:4-benzphenanthrene, and
five of these have been prepared and tested. 5-Methyl-3:4-benzphenanthrene
has only recently been prepared (Newman and Wheatlev, 1948). It is a remark-
able feature of the benzphenanthrenes, which has not yet been explained, that
these compounds are all very much less effective in producing cancer when
administered by injection than when applied to the skin. 3:4-Benzphenanthrene
(X) itself is slightly active to the skin of mice, but has proved ineffective when
administered subcutaneously. 2-Methyl-3:4-benzphenanthrene is a potent car-
cinogen when applied to the skin, but is only very slightly active when adminis-
tered by injection. 1-Methyl-3:4-benzphenanthrene is moderately active to the
skin, and seems to be inactive by injection. The remaining monomethyl deri-
vatives are only slightly active. Only a few dimethyl derivatives have been
tested. These include 6:7-dimethyl-, and 2:9-dimethyl-3:4-benzphenanthrene,
which have been shown to be inactive by injection; but since these compounds
have not been tested on the skin no inferences can be drawn.
All the monomethyl chrysenes have been prepared (Bachmann and Edgerton,
1940), but all do not appear to-have been tested. Work in this field is sometimes
difficult to follow, as two systems of numbering the chrysene molecule are about
equally used (Table IV). In America the Patterson system is used, but in Europe
the Richter system is still commonly used, and is used in this report. The
Patterson numbers are given in parenthesis. 1-Methylchrysene (5-) is a potent
carcinogen, and 2-methyl-(6-), and 6-methylchrysene (4-) are slightly active.
These results apply only to tests by subcutaneous injection, and since there is
some evidence that the alkylchrysenes, like the alkylbenzphenanthrenes, aremore
potent when applied to the skin, the relative carcinogenic activities of these
derivatives should be accepted with caution. 1:2-Dimethylchrysene (5:6-), for
example, is a moderately active carcinogen to the skin of mice, but only very
feebly active when administered by injection. 6:7-Dimethylchrysene (4:5-) and
6:7-methylenechrysene (4:5-) are feebly active by injection, but have not been
tested by application to the skin.
Relatively little work has been done on the homologues of triphenylene,
naphthacene, and pyrene. Triphenylene itself is not carcinogenic, and the 1-
methyl- and 1:4-dimethyl-derivatives also appear to be inactive, at least when
administered by injection (Shear and Leiter, 1941). Naphthacene derivatives
are very readily photo-oxidized, and are not therefore very suitable for test
(23rd Annual Report, B.E.C.C., 1946, p. 109). 2-isoPropylnaphthacene has been
tested for comparison with its cancer-producing isomer, 6-isopropyl-1:2-benzan-
thracene: it did not induce tumours (Barry et al., 1935). Pyrene and 4-methyl-
pyrene are also inactive (Barry et alo, 1935; Badger et al., 1940).
There are fifteen possible pentacyclic aromatic hydrocarbons composed
entirely of benzene rings, and all have been tested for cancer-producing activity
(Barry et al., 1935). 1:2:5:6-Dibenzanthracene (I) was the first pure synthetic
substance shown to be carcinogenic; 1:2:7:8-dibenzanthracene has given a few
tumours in very extensive tests, and is only very feebly active; 1:2:3:4-dibenzan-
thracene seems to be inactive. 3:4-Benzpyrene (III) is a very potent carcinogen,
but 1:2-benzpyrene (IV) is inactive. 1:2:5:6-Dibenzphenanthrene (XV) and
1:2:3:4-dibenzphenanthrene (XVI) are moderately active, and the remaining
318CARCINOGENIC HYDROCARBONS
pentacyclic hydrocarbons are inactive. Itisinteresting that ofthe fifteen possible
pentacyclic hydrocarbons, thirteen may be considered as derived from phenan-
threne, and only five of these have given tumours.
/X //\
5W\AC/J 131A
XV. XVI.
A few homologues of 1:2:5:6-dibenzanthracene have been examined with
interesting results. 2'-Methyl-, 3'-methyl-, and 4-methyl-i:2:5:6-dibenzanthra-
cenes are all weakly to moderately active (Cook, 1932b; Barry et al., 1935).
1':9-Methylene-1:2:5:6-dibenzanthracene (XVII) is moderately active (Shear,
1936a); but 9-methyl-1:2:5:6-dibenzanthracene (XVIII) is an extremely potent
carcinogen (Shear, Leiter and Perrault, 1940). It is therefore surprising that
9:10-dimethyl-1:2:5:6-dibenzanthracene is only very feebly active, having pro-
CH2 CH3 11
IIJ9)>-S ~~~~~~~~~~~~~~~~~~~~~~~~~IIJ0X
XVII. XVIII.
duced only one papilloma. This result, which appears to run contrary to the
1:2-benzanthracene series, was observed in the early work (Cook, 1932b), and
materially delayed the recognition of the importance of the meso substitution
in the related series. It is also noteworthy that although 9:10-dimethyl-1:2:3 4-
dibenzanthracene is inactive, as might be expected, 9:10-dimethyl-1:2:7:8-
dibenzanthracene is a potent cancer-producing substance (23rd Annual Report,
B.E.C.C., .1946, p. 107). These observations-have been offered in support of the
hypothesis linking carcinogenic activity with an activated phenanthrene-type
bond (Haddow, 1947).
The effect of methyl groups on the activity of 3:4-benzpyrene is also of con-
siderable interest as, here again, the effect seems to run counter to that which
might be expected from a consideration of the methylbenzanthracenes. 2'-
Methyl- and 3'-methyl-3:4-benzpyrenes appear to be inactive, at least when
administered by injection, although these positions of substitution correspond to
the 7- and 6- positions in benzanthracene. Furthermore, 4'-methyl- and 6-
methyl-3:4-benzpyrene are considerably less active than the parent hydrocarbon
(III). Again, 9-methyl-3:4-benzpyrene and 5-methyl-3:4-benzpyrene appear to
have the same activity as the parent hydrocarbon. The 9- position corresponds
to the 3'- position in benzanthracene, and 3'-methyl-1:2-benzanthracene is
inactive.
Only afew examples ofhexacyclic aromatic hydrocarbons have beenexamined,
Both 1:2:3:4-dibenzpyrene and 3:4:8:9-dibenzpyrene (XIX and XX) are active,
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TABLE II.-Methylbenzanthracenes, Acebenzanthracene8 and Cholanthrenes.
1':
8 9
7
6
5 10 4
Benzanthracene numi
Compound.
1:2-Benzanthracene
l'-Methyl-
2'-Methyl-
3'-Methyl-
4'-Methyl-
3-Methyl- .
4-Methyl-.
5-Methyl-.
6-Methyl- .
7-Methyl- .
8-Methyl-.
9-Methyl-.
10-Methyl-
1':10-Dimethyl-
2':6-Dimethyl-
2':7-Dimethyl-
3':6-Dimethyl-
3':7-Dimethyl-
3:9-Dimethyl-
4:9-Dimethyl-
4:10-Dimethyl-
5:6-Dimethyl-
5:8-Dimethyl-
5:9-Dimethyl-
5:10-Dimethyl-
6:7-Dimethyl-
8:10-Dimethyl-
9:10-Dimethyl-
4':3-Ace-
4:10-Ace-
5:10-Ace-(Cholanthrene)
8:9-Ace-
5:9:10-Trimethyl-
6:9:10-Trimethyl-
20-Methylcholanthrene
22-Methylcholanthrene
23-Methylcholanthrene
7-Methyl-8:9-ace-
5:6:9:10-Tetramethyl-.
2'
3'
j/4'
bering.* Cholanthrene numbering.t
Carcinogenic activity.
Skin. References. Subcutaneous References. tissue.
0 . a . 0 . e
0 . b . 0 . b,c,e
0 . a . ..
0 . a . ..
0 . b . ..
+ .a,b. F++. b
+ . a . ++ . e
++ . a . ++ . d
+ . a.
+ . a,b. + . b,d
+ . b 0 . e
++ . b .±+++- . d
+++- . b .F++++- . d
0 . f
0 . a,g . 0 . a,g
0 . a .
0 . a .
0 . a .
0 . e
. +++. e
++ . f
0 . h
. ++++. d
..++++. d
+F . a. .. . .
. +++. h
. ++++ . b . +++ .b, d, f,h
+ . b . ++ . b
.. .. .+++ .d,h
.-J-+-F-+++. j . ++++- . k,
++ . k
.±++++ . b, m . +++ . b
.±-F+F+F. b,g .< ++ . b
. +++-+--F. j .--F +-++. 1
.. .. .++++. 1
.. .F.F++++. I
0 . k
+- F. b . +F . b
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and so also is 7-methyl-1:2:3:4-dibenzpyrene. All the other hexacyclic aromatic
hydrocarbons which have been tested have failed to give rise to tumours (Kleinen-
berg, 1938, 1939, 1940; Bachmann, Cook, Dansi, de Worms, Haslewood, Hewett
and Robinson, 1937).
2 /X~~~~~~~~~~~~~~~~~~~~ a
XIX. XX.
TABLE III.-M7ethylbenzphenantl&renes.
6
3~~~~~~
2 9~~~~~~
7 A
1 10
Carcinogenic activity.
Compound.
Skin. References. Subcutaneous References. tissue.
3:4-Benzphenanthrene . . + . a, c . 0 . c, d
1-Methyl- . . . . . ++ . c . 0 . c
2-Methyl-. . . . . . b, c . + . c, d
6-Methyl-. . . . . + . c . + . c
7-Methyl-. . . . . + . c . 0 . c
8-Methyl-. . . . . + . c . 0 . c
2:9-Dimethyl- . . . . .. . .. . 0 . d
6:7-Dimethyl- . . . .. . .. . 0 . e
a, Barry, Cook, Haslewood, Hewett, Hieger and Kennaway (1935); b, Bachmann, Cook,
Dansi, de Worms, Haslewood, Hewett and Robinson (1937); c, Badger, Cook, Hewett, Kennaway,
Kennaway, Martin and Robinson (1940); d, Sear and Leiter (1941); e, Shear (1938).
* This method ofnumbering has been used most extensively in both the chemical and boilogical
literature. It is not, however, the system which is recommended by Patterson. The Patterson
numbering (A) is used in Chemical Abstracts, and has also been used recently in the Journal of the
American Chemical Society.
2
10
8 7 6
(A).
t This is the " sterol " numbering for cholanthrene. For the other systems see footnote to
formula VIII.
References:-a, Barry, Cook, Haslewood, Hewett, Hieger and Kennaway (1935); b, Badger,
Cook, Hewett, Kennaway, Kennaway, Martin and Robinson (1940); c, Shear (1939); d, Shear
(1938); e, Shear and Leiter (1941); f, Shear, Leiter and Perrault (1940); g, Badger, Cook, Hewett,
Kennaway, Kennaway and Martin (1942); h, Dunlap and Warren (1946); i, Shear and Perrault
(1939); j, Bachmann, Cook, Dansi, de Wcrms, Haslewood, Hewett and Robinson (1937); k, Shear
(1936b); 1, Bradbury, Bachmann and Lewisohn (1941); m, Hartwell and Stewart (1942).
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TABLE IV.-Methylchry8enes.
2 3
6
"Richter" numbering.*
Carcinogenic activity.
Compoundl. Skin. References. Subcutaneous Referenc.
tissue. Reenc.
Chrysene . . . . . 0 . a . 0 . c
1-Methyl-. . . . . .. .+++ b
2-Methyl-. . . . . .. + c
6-Methyl-. . . . . .. + b
4:5-Dimethyl- . . . . .. . .. . 0 . d
6:7-Dimethyl- . . . . .. . .. + b
1:2-Dimethyl- . . . . ++ . e . + . b, e
* This system ofnumbering is used in Europe, but the Patterson system (A) is used in America.
1
(A)
a, Bachmann, Cook, Dansi, de Worms, Haslewood, Hewett and Robinson (1937); b, Dunlap and
Warren (1943); c, Shear and Leiter (1941); d, Shear (1938); e, Badger, Cook, Hewett, Kennaway,
Kennaway, Martin and Robinson (1940).
TABLE V.-Methylbenzpyrenes.
1 10
2'8
3' 7
4' 5 6
Carcinogenic activity.
C:ompound. Skin. References. Subcutaneous References.
tissue..
3:4-Benzpyrene. . . . ++++ . a, g . ++++ . a, h
2'-Methyl- . . . . .. . . 0 . c
3'-Methyl- . . . . 0 . b,f,i . 0 .
4'-Methyl- . . . . .. . . ++ . d
5-Methyl-. . . . . .. . .++ ± + . e
6-Methyl- . :. . .. . . +
+ . c
9-Methyl-. . . . . .. . .. . ++++ . c
a, Fieser (1938); b, Schurch and Winterstein (1935); c, Fieser and Heymann (1941); d, Shear
and Perrault (1939); e, Shear, Leiter and Perrault (1940); f, Winterstein, Vetter and Schon (1935);
g, Barry, Cook, Haslewood, Hewett, Hieger and Kennaway (1935); h, Shear (1936a); i, Fieser and
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(b) Alkyl derivatives in homologous series.
There appears to be little doubt that the substitution of one or more methyl
groups into a " favourable " position of certain polycyclic aromatic hydrocarbons
can transform a non-carcinogenic hydrocarbon into a carcinogenic derivative,
or can materially increase the activity of a carcinogen. It was therefore of
interest to study the effect of the higher alkyl groups.
The 5-n-alkyl-1:2-benzanthracenes have been extensively investigated, for
all the members ofthe series as far as the n-heptyl.derivative have been examined,
most of them by both injection, and painting on the skin. When tested by the
latter method all the compounds are active, but there is a progressive diminution
in potency as the number of carbon atoms in the alkyl chain increases, 5-methyl-1:
2-benzanthracene being moderately active, but the 5-n-heptyl derivative being
only very slightly so. A plot of Iball's carcinogenic index for each compound
against the number of carbon atoms in the alkyl chain has been published by
Badger, Elson, Haddow, Hewett and Robinson (1942). When tested by sub-
cutaneous injection, however, the higher members ofthe series (butyl, amvl, hexyl,
and heptyl) failed to give tumours. 5-Methyl-1:2-benzanthracene is moderately
active bv this method, but comparable experiments with the ethyl and n-propyl
derivatives do not appear to have been undertaken. 5-isoPropyl-1:2-benzan-
thracene was found to be moderately active to the skin, and slightly active by
injection.
Of the 10-n-alkyl-1:2-benzanthracenes the methyl derivative is extremely
potent, both by application to the skin and by injection. The ethyl homologue
is rather less active when tested by injection, and the higher homologues have
failed to give tumours when administered by this method. As these compounds
have not been tested by application to the skin, it is difficult to decide whether
activitv is more easily lost in the 10- substituted series or in the 5- substituted
compounds. It is ofsome interest, however, that 10-isopropyl-1:2-benzanthracene
has been tested by both methods and appears to be completely inactive, while
the 5-isopropyl- derivative, which has also been tested by both methods, is
moderately active.
Little work has been carried out on the synthesis and testing of other homo-
logous series of alkylbenzanthracenes. An apparent exception, however, is
6-isopropyl-l : 2-benzanthracene, which appears to be more active than the methyl
derivative: but this comparison has been made only on the skin of mice, and
not by injection. 3-isoPropyl- and 7-isopropyl-1:2-benzanthracenes have also
been tested on the skin and found to be inactive; the corresponding methyl
derivatives are very slightly active. 20-Methylcholanthrene is rather more
potent than the parent hydrocarbon, cholanthrene; the higher members of this
series, namely, the ethyl-, isopropyl.-, and tert.-butyicholanthrenes are progres-
sively less potent when tested by injection.
A short series of 2-alkyl-3:4-benzphenanthrenes has also been examined. In
skin-painting experiments the 2-methyl- derivative proved very potent, and the
2-ethyl- and 2-isopropyl- derivatives were found to be less active. The benz-
phenanthrenes always show greater activity when tested on the skin than when
given by injection, and the present series is no exception; 2-methyl-3:4-benz-
phenanthrene was found to be only feebly active by this latter method, and the
2-isopropyl- derivative failed to give any tumours.
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TABLE VI.-Alkyl Dern
Compound.
5-Methyl-1:2-benzanthracene
5-Ethyl- .
5-n-Propyl-
5-isoPropyl-
5-n-Butyl-
5-n-Amyl-
5-n-Hexyl-
5-n-Heptyl- .
ivatives in Homologous Series.
Carcinogenic activity.
O- Al
Subcoutaneous Skin. References. tissue tissue.
++ . a * ++
++ . b
b
c
c
c
c
d
* ±
0 * 0
* 0
O
10-Methyl-1:2-benzanthracene
10-Ethyl-
10-n-Propyl-
10-isoPropyl-
10-n-Butyl-
10-n-Amyl-
20-Methylcholanthrene
20-Ethylcholanthrene
20-isoPropylcholanthrene
20-t-Butylcholanthrene
C,f . ++++ -. f
0 a
0
0
0
0
. ++++ . b . ++++
* *.- * . . +++
* *.* * .* . +
2-Methyl-3:4-benzphenanthrene
2-Ethyl-
2-isoPropyl-
2-n-Propyl-
+++
++
++
c
c, d
c
d
* +
*z0
0
c
c
d
a, Barry, Cook, Haslewood, Hewett, Hieger and Kennaway (1935); b, Bachmann, Cook, DanQi,
de Wormrs, Haslewood, Hewett and Robinsen (1937); c, Badger, Cook, Hewett, Kennaway,
Kennaway, Martin and Robinson (1940); d, Badger, Cook, Hewett, Kennaway, Kennaway and
Martin (1942): e, Shear (1938); f, Shear, Leiter and Perrault (1940); g, Shear, Leiter and
Perrault (1941).
(c) The effect of other substituents.
Although most of the early work was concentrated on an examination of
hydrocarbons, a few derivatives carrying functional substituents were examined.
9-Amino-1:2:5:6-dibenzanthracene, and 9-methoxy-1:2:5:6-dibenzanthracene, for
example, were found to be moderately active. On the other hand, the introduc-
tion of other substituents at the same position gave rise to inactive derivatives;
these included the 9-nitro-, 9-hydroxy-, 9-acetoxy-, and 9-n-butyrylamino- sub-
stituted 1:2:5:6-dibenzanthracenes (Barry et al., 1935). As has been pointed out
above, 9-methyl-1:2:5:6-dibenzanthracene is a potent carcinogen, more active
than the parent hydrocarbon (Shear, Leiter and Perrault, 1940).
Several substituted methylcholanthrenes have been tested (Shear, Leiter and
Perrault, 1941). These include the 2-hydroxy-, 2-methoxy-, 3-hydroxy-, and
3-methoxy- derivatives, all of which are inactive. The effect of substitution on
the dimethylene bridge is not so striking, however, for 15-hydroxy-20-methyl-
References.
e
* C
* *C c
c
c
d
c
f
f
f
f
f
e
e, g
g
g
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cholanthrene is still moderately active, and the corresponding keto derivative is
slightly active. 6-Chloro- and 6-cyano-20-methylcholanthrenes are inactive.
In the above cases the effect of the substituent (other than methyl) has been
to reduce the potency of the original hydrocarbon, and in some cases to abolish
the activity altogether. Several functional derivatives of 9:10-dimethyl-1:2-
benzanthracene have been examined, however, and in these cases the activity
of the parent hydrocarbon seems to be retained. 5-Bromo- and 5-cyano-9:10-
dimethyl-1:2-benzanthracenes have about the same activity as the parent di-
methylbenzanthracene (Dunlap and Warren, 1946).
Substitution in the methyl groups ofthis hydrocarbon does reduce the potency.
9-Methyl-10-ethoxymethyl-, 9-methyl-10-methoxymethyl-, 9:10-bishydroxy-
methyl-, and 9:10-bisacetoxymethyl-l:2-benzanthracenes are all appreciably
less active than 9:10-dimethyl-l:2-benzanthracene (Dunlap and Warren, 1946;
Badger, Cook, Hewett, Kennaway, Kennaway, Martin and Robinson, 1940).
The type of substituent is clearly of great importance, but (as with methyl
groups) the position of substitution is also of considerable importance, although
it must not be assumed that the "favourable " positions for polar substituents
are the same as the "favourable" positions for alkyl groups. Benzpyrene and
5-methyl-3:4-benzpyrene are potent carcinogens, for example, and 5-methoxy-
3:4-benzpyrene is only very slightly active, while 8-methoxy-3:4-benzpyrene is a
potent carcinogen (21st Annual Report, B.E.C.C., 1944, p. 56).
The activity or otherwise of the metabolic products of polycyclic aromatic
hydrocarbons is of some interest (see p. 332). 4'-Hydroxy-1:2-benzanthra-
cene, the metabolic product of the non-carcinogenic 1:2-benzanthracene, is also
inactive (23rd Annual Report, B.E.C.C., 1946, p. 98). Similarly, 4':8'-dihydroxy-
1:2:5:6-dibenzanthracene, the metabolite of dibenzanthracene in mice and rats,
is not carcinogenic. In rabbits 1:2:5:6 dibenzanthracene is metabolized to a
dihydroxv dibenzanthracene of unknown orientation, and this product is also
inactive as a carcinogen (Boyland, Levi, Mawson and Roe, 1941; Dobriner,
Rhoads and Lavin, 1942). 8-Hydroxy-3: 4-benzpyrene, one of the metabolites
of benzpyrene, is only very slightly carcinogenic (21st Annual Report, B.E.C.C.,
1944, p. 56).
The above work mostly concerns the effect of substituents on carcinogenic
hydrocarbons; but the effect of various groups on non-carcinogenic compounds
is perhaps even more important. Benzanthracene is perhaps the most important
non-carcinogenic hydrocarbon, as it is the parent substance of so many of the
more interesting carcinogens. A large number of 10- substituted derivatives
of benzanthracene has been examined, for substituents can easily be introduced
into this position, either by substitution reactions, or by replacement. Many of
these derivatives are tabulated in Table VII. Some derivatives are carcinogenic
and some are inactive. In most cases the activity is ofa low order, but the interest-
ing feature of this work is that bothl electron-attracting and electron-repelling sub-
stituents can convert the inactive benzanthracene into a cancer-producing deriva-
tive. 10-Methyl-, 10-amino-, 10-mercapto-, and 10-methoxy-1:2-benzanthracenes
are cancer-producing, but so also are the 10-cyano- and 10-aldehyde-derivatives.
In this connection it is noteworthy that 9-methyl-10-cyano-1:2-benzanthracene is
a potent carcinogen, with activity of the same order as that of9:10-dimethyl-1:2-
benzanthracene (Badger, Cook, Hewett, Kennaway, Kennaway, Martin and
Robinson, 1940).
23
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TABLE VII.-1O-Substituted-1:2-benzanthracenes.
Substituent in the 10-position.
-CH3.
- CH2CN
- CH2C1 .
- CH2SH
CH20H
CH20CH3
CH20COCH3
- CH20CH2CH3
- CH2NMe2
- CH2NEt2
- CH2C00H
- CH2COOCH3
-OH
-OCH3 *
NO2
-NH2
-OCN
-SH
-NCO
-CHO
-CHOH.CH3
- COCH3
Carcinogenic activity.
Skin. R6ferences. Subuteous References.
* ++-
* *±±
* +H
*+
0
a . ++++
* *.- ±
* .. . 0
* *. . +
* a. . + +
* .. . 0
* a +++
a
e
e
0
0
0
0
+
0
++
0
±
+
0
b
d
d
d, c
d, a
d
d, a
a
d
d
d
d
d
d
d
d, a
d, a
c
c
d
d
a, Badger, Cock, Hewett, Kennaway, Kennaway, Martin and Robinson (194G); b, Shear (1938);
c, Dunlap and Warren (1946); d, Shear, Leiter and Perrault (1940); e, Badger, Cook, Hewett,
Kennaway, Kennaway and Martin (1942).
(d) Heterocyclic and fluorene analogues.
Following the discovery that 1:2:5:6-dibenzanthracene has moderate carcino-
genic activity, it was of interest to examine certain heterocyclic analogues and
related fluorene derivatives, and considerable work in this field has now been
carried out. 1:2:5:6-Dibenzanthracene (XXI), 1:2:5:6-dibenzfluorene (XXII),
1:2:5:6-dibenzacridine (XXIII) and 1:2:5:6-dibenzearbazole (XXIV) are a11
slightly to moderately active, while 1:2:5:6-dibenzphenazine (XXV) and iso-
naphthathioxin (XXVI) appear to be inactive.
II
6 12
11 2
II
XXI.
Il!
16 11 11 2
11 XX
\4e
XXII. XXiiI.
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6 1 1 21
XX
XXIV.
II YN II
XXV.
I1 II
5//
11 XX
XXVI.
Again, 1:2:7:8-dibenzanthracene (XXVII), 3:4:5:6-dibenzacridine (XXVIII;
1:2:7:8-dibenzacridine inAmerican numbering), 1:2: 7:8:dibenzfluorene (XXIX),
1:2:7:8-dibenzcarbazole (XXX), and 3:4:5:6-dibenzcarbazole (XXXI) havegiven
tumours, while 3: 4: 5: 6-dibenzfluorene appears to be inactive (Hartwell, 1941).
The effect of the introduction of one or more hetero atoms in the meso positions
H 1 11
\/8\/i1\ 17 11 2
XXVII.
11 11
7 Ii 11 21
XXX.
/\~~~~//\1
~N/4\
6 H
XXXII. 5/\ J4\)
6 11 11 31
\Dxi
81 11
~~~~\ /8\/\1X
7 1! Ii 2
XXIX.
H II
\/5 /4X/ 6 41 11 3
XXXII.
is therefore somewhat irregular, but many heterocyclic analogues may possess
activity ofa high order. 3:4:5:6-Dibenzcarbazole is particularly potent (Boyland
and Brues, 1937; Andervont and Edwards, 1941). It is also of some interest
that Kirby and Peacock (1946) have found N-methyl-3:4:5:6-dibenzcarbazole less
effective than the parent substance in producing either tumours or hyperplastic
liver changes in mice. 1:2-Benzcarbazole has been reported as very slightly
carcinogenic by Schurch and Winterstein (1935), and this observation should
clearly be confirmed by other workers. Several N-alkyl derivatives (methyl,
ethyl, propyl) appear to be inactive (Buu-Hoi, 1946), so that meso substitution
seems to be effective only in an aromatic hydrocarbon ring.
A few examples of derivatives with hetero atoms at positions other than the
meso positions have been examined. 1'-Aza-3:4-benzpyrene (XXXIII) and
'-aza-3:4-benzphenanthrene (XXXIV) appear to be completely inactive. 3-Aza-
chrysene (XXXV), 5-aza-1:2-benzanthracene (XXXVI) and 4'-aza-1:2-benzan-
thracene (XXXVII), which are related to non-carcinogenic hydrocarbons, are
also inactive (Badger, Cook, Hewett, Kennaway, Kennaway, Martin and Robin-
son, 1940; ShearandLeiter, 1941 ; Joseph, 1939). Itis ofsomeinterest, however,
that the latter compound, 4'-aza-1:2-benzanthracene, gave small tumour nodules
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II
XXXIII.
1'-Aza-3:4-benzpyrene
3(N):4-Pyridinopyrene.
11 1 1 ~~~~~~~~il Il \/XS/
XXXIV.
1'-Aza-3:4-benzphenanthrene
Naphtho(1:2f)quinoline
3(N):4-Pyridinophenanthrene.
\/\\/\ I
l11
XXXV.
3-Azaclirysene (British).
1-Azachrysene (American).
Naphtho(2:lf)quinoline.
11
-N
fl( D\
XXXVII.
4'-Aza-1:2-benzanthracene
Naphtho(2:3f)quinoline
3-Anthraquinoline.
il
I 11
xx/xAD XXXVI.
5-Aza-1:2-benzanthracene
Naphtho(1:2g)quinoline.
in the kidney in 2 of 11 rats injected subcutaneously. 1: 2-Benzanthracene itself
appears to have some activity in rats, for it gave hepatomas in 2 of 6 rats of the
Osborne and Mendel strain which were given this hydrocarbon by mouth (Sem-
pronj and Morelli, 1939; White and Eschenbrenner, 1945).
Activity of a very high order has been found in certain sulphur compounds
closely related to 9:10-dimethyl-1:2-benzanthracene. 4:9-Dimethyl-5:6-benz-
thiophanthrene (XXXVIII) has produced tumours in an average time of 116
CH3 II
CH3
XXXVIII.
days, and thus has activity of the same order as that of the parent hydrocarbon
(Dunlap and Warren, 1941; Sandin and Fieser, 1940). It also proved to be
highly active when administered by injection; tumours were produced in an
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average of 18 weeks (100 per cent response), as compared with a latent period of
14 weeks with the hydrocarbon. Hershberg and Fieser (1941) have also prepared
9:10-dimethyl-1:2-(2':3'-thiopheno)anthracene (XXXIX) and the corresponding
selenium analogue (XL), but the biological tests do not seem to have beenreported
(Fieser, 1944).
CH3 2p CH Se-i
/9112X3 2 I
CH3 CH3
XXXIX. XL.
Compounds in which the sulphur atom replaces the phenanthrene-type double
bond have been prepared by a group of workers under Sir Robert Robinson
(23rd Annual Report, B.E.C.C., 1946, p. 107). 4:7-Dimethyl-2:3:5:6-dibenzthio-
naphthene (XLI) was found to be moderately active by application to the skin,
but proved inactive when administered by injection. On the other hand, 4:9-
dimethvl-2:3:5:6-dibenzthiophanthrene (XLII), which again possesses a phenan-
CH3 fl CH3 II
ZI 1! 2/ 16 2/
s \S CH3 RH3
XLI. XLII.
threne-type double bond, is a particularly potent carcinogen both to the skin and
to subcutaneous tissue. Furthermore, the isomeric 4:9-dimethyl-2:3:7:8-dibenz-
thiophanthrene is also a potent carcinogen (24th Annual Report, B.E.C.C., 1947,
p. 126).
The effect of alkyl substitution in the heterocyclic series of carcinogens has
not been widely studied, except in the benzacridine series, and here some interest-
ing differences between the 1:2-benzacridines and the -3:4-benzacridines have
emerged. This work is particularly difficult to follow, as so many different
systems of numbering the acridine molecule are in common use. The system
used here is that commonly used by British chemists, but it differs from that used
in America, where the Patterson system is used. It also differs from that cur-
rently used in French papers, where most of this work has been reported. Thus
3:4-benzacridine in Britain is the same as 1:2-benzacridine in America, and this
is the same as 5:6-benzacridine in the French papers.
9 I6 5
8/\ 7 \4// 71 II8 ,/K II 3I
7\/ /\\/3 8\ 2<
6 5 4 9 1
XLIII. XLIV.
1:2-Benzacridine. 3:4-Benzacridine.
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TABLE VIII.--Methylbenzacridines.
3'
4' 2'
6 5
7
N/ 2
9
3:4-Benzacridine.*
Compound.
3:4-Benzacridine
5-Methyl- .
7-Methyl- .
5:7-Dimethyl-
5:8-Dimethyl-
5:9-Dimethyl-
2':5:9-Trimethyl-
5:7:9-Trimethyl-
1:2-Benzacridine
5-Methyl- .
7-Methyl- .
5:7-Dimethyl-
5:8-Dimethyl-
5:9-Dimethyl-
5:7:9-Trimethyl-
5:6:7:9-Tetramethyl-
1:2-Benzacridine.
Carcinogenic activity.
Skin. References. Subcutaneous References. tissue.
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The mono-methyl derivatives of 3:4-benzacridine are either inactive, or only
slightly active, but the introduction of several methyl groups, as in 5:7:9-tri-
methyl-3:4-benzacridine, gives rise to more potent derivatives. On the other
hand, the mono-methyl derivatives of 1:2-benzacridine are, generally speaking,
moderately or markedly carcinogenic. 5:9-Dimethyl-, 5:8-dimethyl-, and 5:7-
dimethyvl-1:2-benzacridines are extremely potent carcinogens, approaching
methylcholanthrene in activity (Lacassagne, Rudali, Buu-Hoi and Lecocq, 1945;
Lacassagne, Buu-Hoi, Lecocq and Rudali, 1946; Buu-Hoi, 1946).
(e) Hydroaromatic comtpounds.
The biological activity of hydrogenated derivatives of polycyclic aromiiatic
hydrocarbons is of special interest, partly in view of the possibility that carcino-
genic hydrocarbons may be formed in vivo from sterols or other normal con-
stituents of animal cells, and partly with reference to the influence of the shape
and size of the molecule on carcinogenic activity (Fieser, 1944).
In connection with the first point, it was clearly ofimportance to test dehydrn-
norcholene (VII), the immediate precursor of methylcholanthrene in the labora-
tory preparation of this carcinogen from deoxycholic acid. It proved to be
inactive, however (Shear, 1938; Bachmann, Cook, Dansi, de Worms. Haslewood,
Hewett and Robinson, 1937).
It is also important that 6:7-dihydro-20-methylcholanthrene is inactive
(Shear, Leiter and Perrault, 1-941), for in this hydrocarbon only the phenanthrene-
type double bond has been hydrogenated. On the other hand, hydrogenation
does not always give rise to inactive compounds. 1':2':3':4'-Tetrahydro-4: 10-
ace-1:2-benzanthracene is slightly active, having produced 4 tumours in 10 imiice
which received the compound by injection (Shear, 1938). No tumours were
produced, however, with the related 1':2':3':4'-tetrahydro-10-methyl-1:2-benzan-
thracene; nor with 9:10-dihydro-10-methyl-1:2-benzanthracene; nor with
5:6:7:8-tetrahydro-10-nethyl-1:2-benzanthracene (Shear, 1939).
Of the compounds related to 3:4-benzpyrene which have been tested, 1':2'-
dihydro-4'-methyl-3:4-benzpyrene proved to have about the same activity as the
corresponding fully aromatic compound, but 1':2':3':4'-tetrahydro-3:4-benzpyrene
gave no tumours when injected into mice, although the duration ofthe experimient
was 20 months (Shear, 1939).
THE METABOLISM OF POLYCYCLIC AROMATIC HYDROCARBONS
So far as is known the carcinogenic and related non-carcinogenic polycyclic
aromatic hydrocarbons all undergo hydroxylation or perhydroxylation in the
animal body, and there does not seem to be any essential difference between the
metabolism of the carcinogens as opposed to the non-carcinogens. There is
some species specificity, however, in that rabbits metabolize the hydrocarbons
by a process which differs slightly from that of mice and rats (Boyland and
Weigert, 1947).
oa-Naphtholglycuronic acid has been isolated from the urine of dogs dosed
with naphthalene, and l-cx-naphthylmercapturic acid from the urine of rabbits.
Recently Young (1946) has isolated 1-1:2-dihydroxy-1:2-dihydronaphthalene fi-om
the urine of rats dosed subcutaneously or orally with naphthalene, and following
331G. M. BADGER
similar experiments with rabbits Booth and Boyland (1947) have obtained a
dl-1:2-dihydrodiol.
Anthracene is metabolized by a similar process. The major product in the
urine ofboth rats and rabbits is a 1:2-dihydrodiol and monoglycuronide. Rabbits
appear to produce dl-1:2-dihydroxy-1:2-dihydroanthracene, and rats the corre-
sponding 1-compound (Boyland and Levi, 1935; 1936a, b).
Such dihydrodiols are very readily dehydrated to phenols, and it is, therefore,
not necessarily significant that dihydrodiols have not been isolated following
experiments with the more complex hydrocarbons. In such experiments only
phenols have been isolated (or characterized by the formation of a more stable
methylether), although there is some evidence for the formation of suclidihydro-
diols (Weigert and Mottram, 1946a, b).
Berenblum and Schoental (1943b) have found that 1:2-benzanthracene is meta-
bolized to the 4'-hydroxy-derivative (XLV), and the potent cancer-producing
substance 9:10-dimethyl-1.:2-benzanthracene is probably metabolized to 4'-hy-
droxy-9:10-dimethyl-1:2-benzanthracene (XLVI) (22nd AnnualReport, B.E.C.C.,
1945, p. 53). In both cases rats were used, and no experiments with rabbits have
yet been reported. Chrysene is metabolized to 3-hydroxychrysene (XLVII;
l-hydroxychrysene in American numbering) (Berenblum and Schoental, 1945).
Similarly, 3:4-benzpyrene is metabolized to 8-hydroxy-3:4-benzpyrene (XLVIII),
although some 10-hydroxy-3:4-benzpyrene is also formed in small quantity. In
rabbits the process is similar except that more of the 10-hydroxy- derivative
is formed (Berenblum and Schoental, 1946b).
I3!
I (H, 4< ~~OHI f
,/X/\\,/OH // OH Ii I\/OH
\/%>\S</ /X \/O 1 i.'
OHi,
XLV. XIVI. - XLVII. XLVIII.
1:2:5:6-Dibenzanthracene is oxidized to 4':8'-dihydroxy-1:2:5:6-dibenzan-
thracene in rats and mice (Dobriner, Rhoads and Lavin, 1942), but to another
dihydroxy derivative (ofunknown orientation) in rabbits (Boyland, Levi, Mawson
and Roe, 1941 ; Dobriner, Rhoads and Lavin, 1942; Badger, 1947).
These metabolism experiments are of considerable interest for two reasons.
Firstly, as Boyland and Weigert (1947) have emphasized, the species differences
in metabolism may not be unconnected with carcinogenic action. Although
1:2:5:6-dibenzanthracene readily produces tumours at the site of injection in
rats andin mice. it very rarely, ifever, produces such tumours inrabbits. Secondly,
it is noteworthy that in rats the polycyclic aromatic hydrocarbons all give rise
to phenols in which the hydroxyl groups occupy comparable positions. The 4'-
position of benzanthracene (and of its 9:10-dimethyl- derivative) is comparable
with the 3- position in chrysene, and with the 8- position in 3:4-benzpyrene. In
general, however, oxidizing reagents do not attack these positions (Cook and
.Schoental, 1947), and the biological oxidation must therefore be conditioned by
additional or other factors. It must be admitted, however, that in all metabolic
experiments the end-product isolated represents only a small fraction of the
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aiiount of hydrocarbon administered. The greater part of the hydrocarbon
must be broken down into simple products which escape isolation.
THE CHEMICAL REACTIVITY OF CARCINOGENS.
Many of the most potent carcinogenic hydrocarbons are extremely reactive,
and take part in substitution and addition reactions with very great facility.
This pronounced chemical reactivity of some, but not all the carcinogens has
attracted the attention of several workers, and many attempts have been made
to find correlations between the chemical properties of the molecules and their
cancer-producing activity. Probably the most extensive work in this field has
been carried out by L. F. Fieser and his associates, who, in a number of papers,
have developed the hypothesis that carcinogenicity may be associated with some
specific chemical reaction (Fieser, 1938 ; 1944).
The addition of hydrogen to polycyclic aromatic hydrocarbons and to the
cancer-producing substances in particular is complex. With phenanthrene there
are three pronounced stages of hydrogenation, leading to 9:10-dihydro-, to
1:2:3:4-tetrahydro-, and 1:2:3:4:5:6:7:8-octahydrophenanthrene. Similarly, with
anthracene there are three stages of reduction. Mild reduction gives the 9:10-
dihydro- derivative, and more vigorous treatment gives the 1:2:3:4-tetrahydro-
and 1:2:3:4:5:6:7:8-octahydro- derivatives. Mostofthe carcinogens are derivatives
of phenanthrene, and many are also derivatives of anthracene. The hydro-
genation of such compounds may take a complex course, involving either the
anthracene moiety, the phenanthrene moiety, or both.
The reduction of 1:2-benzanthracene has been investigated by Fieser and
Hershberg (1937). With sodium and amyl alcohol a hexahydride (XLIX) was
obtained; but with hydrogen and platinum 5:6:7:8-tetrahydro-1:2-benzanthra-
cene (L) was formed. Reduction of the cancer-producing 10-methyl-1:2-benzan-
thracene proceeded in a similar fashion; sodium and amyl alcohol gave the cor-
responding hexahydride, and hydrogen and platinum the corresponding tetra-
hydride. Furthermore, treatnient of 10-methyl-1:2-benzanthracene with sodium,
followed by treatment with alcohol, gave the dihydride (LI) expected from an
anthracene derivative. These authors also made the very interesting observation
cH,
XLIX. L. LI.
that the meso dihydride (LI) on further hydrogenation with hydrogen and plati-
num gave the hexahydride (corresponding to XLIX), which shows conclusively
that the tetrahydrides (L) are not produced via the meso dihydrides, as might
be expected.
The reduction of methylcholanthrene is again related both to the anthracene
and to the phenanthrene types. Bachmann (1936) obtained the 11:14-dihydride
(LII) by the action of sodium, followed by alcohol, on the parent hydrocarbon.
On the other hand, Fieser and Hershberg (1938a) found that reduction of methyl-
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cholanthrenewith sodium and amyl alcohol gave the hexahydride (LIII), and the
same hexahydride was also obtained by reduction with hydrogen and platinum,
together with some 6:7-dihydro-20-methylcholanthrene (LIV).
CH3 14 CH3 CH3 7 3\/I
LII. LIII. LIV.
The meso positions in anthracene derivatives are always reactive, and it was
therefore of some interest to determine whether carcinogenicity is in any way
bound up with this reactivity. As early as 1931, however, Cook (1931) found
that the carcinogenic 1:2:5:6-dibenzanthracene is less reactive than anthracene
in addition reactions involving the meso carbon atoms. Anthracene and its
derivatives undergo a Diels-Alder type of addition with maleic anhydride to
form 9:10-endosuccinic anhydride derivatives:
H\/- CH-(-CO
CH-CO\
11+1 HIll 0
CH-CO/
H/ ____CH-CO
Bachmann and Kloetzel (1938) found that in organic solvents the reaction
is reversible, and that with different anthracene derivatives the velocity of the
addition varies enormously. The presence of.methyl groups in the meso positions
was found greatly to facilitate the reaction. 9-Methylanthracene reacted faster
than anthracene, and 9:10-dimethylanthracene reacted faster still. Indeed, with
the latter hydrocarbon the addition proceeded at room temperature. The
presence of phenyl groups in the meso positions was found to have the opposite
effect, markedly retarding the reaction. Bachmann and Kloetzel's work indi-
cated that there is no correlation between reactivity of this nature and carcino-
genic activity, for they found that methylcholanthrene reacts about as fast as
benzanthracene, and 1:2:5:6-dibenzanthracene was found to react only slowly.
The photo-oxidation of carcinogenic and related compounds is another
addition reaction involving the meso carbon atoms which has been investigated.
Anthracene itself forms a photo-oxide (Dufraise and GCrard, 1935, 1936, 1937)
(LV), and certainmeso substituted anthraceneand benzanthracene derivatives, and
I III
LV.
even more especially certain naphthacene and pentacene derivatives, form photo-
oxides with very great facility. Shabad (1945) has noted that when 9:10-di-
methyl-1:2-benzanthracene is exposed to light and air for 2 or 3 months it showed
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an appreciable decrease in carcinogenic activity. Similar observations were made
by Bradbury, Bachmann and Lewisohn (1941), who found that the pure hydro-
carbon in acetone protected from light and air produced tumours in an average
of 2-O months, while the corresponding time for the same hydrocarbon in acetone
not protected from light and air was found to be 4.7 months. These observations
are clearly associated -with photo-oxidation. Several cancer-producing hydro-
carbons such as 9:10-dimethyl-1:2-benzanthracene readily form photo-oxides,
but this property is not an invariable characteristic of the carcinogens. Benz-
pyrene, for example, gave no photo-oxide (Cook and MLartin, 1940; Cook, Martin
and Roe, 1939).
Clar (1941) has enmphasized that the linear benz-homologues of anthracene,
such as naphthacene, pentacene, hexacene, and heptacene, undergo all trans-
annular addition reactions, such as photo-oxidation and the addition of maleic
anhydride with increasing facility. Naphthacene and pentacene are known to
be non-carcinogenic, and it is abundantly clear therefore that mneso reactivity is
not associated with carcinogenic activity. Additional evidence to this effect
has been provided by Iball (1940 ; Fieser and Dietz, 1931), who studied the
oxidation-reduction potentials of the quinones derived from carcinogenic and
related non-carcinogenic hydrocarbons. The relative values of the potentials
obtained under identical conditions gives a quantitative comparison of the
chemical reactivity associated with the 9:10-positions of the nucleus. Iball was
unable to find any correlation between the observed potential and the carcinogenic
activity of the hydrocarbon.
The coupling of diazonium reagents with various hydrocarbons has been
investigated by Fieser and Campbell (1938), and many of the most potent car-
cinogens, including 3:4-benzpyrene, methyleholanthrene and cholanthrene were
found to react or couple very readily. With these compounds an intense colora-
tion was produced in a few minutes. These observations are interesting, for this
reaction was previously thought to be confined to phenols, amnines, enols and, to
a nmuch smaller extent, ethylenic compounds, especially conjugated dienes. On
the other hand, there is no specificitv in the reaction for 10-methyl-1:2-benzan-
thracene, 5:10-dimethyl-1:2-benzanthracene and other potent carcinogens did
not react, and several non-carcinogenic hydrocarbons reacted readily.
There have been many attempts to study the oxidation of polycyclic aromatic
hydrocarbons with special reference to carcinogenesis. Most oxidizing agents
react with anthracene and its derivatives to give para quinones. Phenanthrene
and its derivatives are normally oxidized to ortho quinones. Compounds in which
both systems are present, as in benzanthracene, normally react predominantly
as derivatives of anthracene. Chromnic acid, for example, oxidizes benzanthracene
to 1:2-benzanthra-9: 10-quinone. Although chromic acid oxidation of 1:2:5:6-
dibenzanthracene gives rise to 1:2:5:6-dibenzanthra-9:10-quinone, some 1:2:5:6-
dibenzanthra-3:4-quinone is also formed (Cook, 1933a).
The effect of special or unusuEl oxidizing reagents has been investigated with
interesting results. Warren (1943), for example, found that certain hydro-
carbons undergo aerobic oxidation in the presence of ascorbic acid, and that this
oxidation is inhibited by KCN and by H3PO3, but is unaffected by hydrogen
peroxide. Anthracene is oxidized to anthraquinone, and benzpyrene to a mixture
of 3:4-benzpyrene-5:8-quinone and the 5:10-quinone, together with an alkali-
soluible compound which could not be isolated. This reaction is ofspecial interest,
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for Kennaway, Kennaway and Warren (1944) have found that benzpyrene and
some other carcinogens caused an increase in the concentration of ascorbic acid
in the livers of mice, while naphthalene, anthracene and phenanthrene caused
no such increase.
Cook and Schoental (1947) have investigated the oxidation of polycyclic
aromatic hydrocarbons with osmium tetroxide. In the presence of pyridine this
reagent was found to add exclusively to adjacent carbon atoms to form complexes
which, on hydrolysis, gave rise to dihydrodiols. Indeed, osmium tetroxide
appears to be a "double bond" reagent in that it does not (under these conditions)
attack reactive centres, but only very reactive aromatic double bonds, and
ethylenic double bonds. 1:2-Benzanthracene was oxidized to the 3:4-dlihydrodiol
(LVI), pyrene to the 1:2-dihydrodiol (LVII) and chrysene to the 1:2-dihydrodiol
(LVIII). Related careinogenic hydrocarbons, such as 9:10-dimethyl-] :2-benz-
OH H
II ~~~~H H\
I '-OH ~~~OH HO-1 OH I~~~-OH
HO H 7'
LVI. LVII. LVIII.
anthracene, methylcholanthrene, and benzpyrene also reacted to give similar
diols.
In spite of the fact that this reagent attacks double bonds, it will be noted
that the position of attack differs from that experienced in biological oxidation
(p. 332). If benzanthracene undergoes perhydroxylation in vivo, as is commonly
assumed in order to account for the isolation of phenolic derivatives, this bio-
logical oxidation must take place at the 3':4'-bond, and yet osmium tetroxide
attacks the 3:4-bond. Again, anthracene is oxidized in vivo to the 1:2-dihydro-
diol, a compound which contains an ethylenic double bond. With osmium
tetroxide, anthracene gives the 1:2:3:4-tetrol (Cook and Schoental, 1948).
Perbenzoic acid is another reagent which probably attacks aromatic double
bonds in preference to reactive centres. Eckhardt (1940a) has studied the rate
of oxidation of several compounds with this reagent. The oxidation products
were not deterniined, the oxidation simply being followed iodometrically over a
7--15-day period. Certain carcinogens such as methvlcholanthrene and benz-
pyrene reacted very rapidly, while other non-carcinogens, such as pyrene, reacted
only slowly. The correlation was not complete, however, and the reaction
should certainly be further investigated.
The oxidation of polycyclic aromatic hydrocarbons with lead tetra-acetate
has been investigated by Fieser and Hershberg (1938c). Here, again, some ofthe
carcinogens reacted with great facility, while others proved to be more resistant
to oxidation. Furthermore, some non-carcinogens were attacked while some
carcinogens were unaffected. 1:2-Benzanthracene was converted into the 10-ace-
toxy- derivative, but the carcinogenic 1:2:5:6-dibenzanthracene was not attacked.
It has been suggested that this lack of reactivity in meso positionis adjacent to an
angular ring is due to steric effects, but there is some reason to believe that the
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9- position in benzanthracene and the 9:10 positions in dibenzanthracene are
inherently less reactive than the meso positions in anthracene (Iball, 1940;
Pullman, 1947a). Other carcinogenic agents, such as 10-mnethyl-1:2-benzan-
thracene, methylcholanthrene, and benzpyrene, were readily attacked by lead tetra-
acetate. Benzpyrene gave 5-acetoxy-3:4-benzpyrene (Fieser and Hershberg,
1939), a product which is analogouis to that obtained from benzanthracene.
10-Methyl-1:2-benzanthracene was attacked on the methyl group to give 10-
acetoxymethyl-1:2-benzanthracene, and methylcholanthrene was attacked on the
methylene group directly attached to the meso position. The reaction, therefore,
provides a useful method for probing for the active centres in a molecule, whether
such centres are located in the nucleus or in a side chain.
Badger and Cook (1939) extended the reaction to the very feebly active
9:10-dimethylanthracene, and the potent carcinogen, 9:10-dimethyl-1:2-benzan-
thracene, and found that both hydrocarbons react very readily. The methyl
groups were found to be attacked in each case, the products isolated being 9:10-
di(acetoxymethyl)anthracene and 9: 10-di(acetoxymethyl)- 1:2-benzanthracene.
High reactivity of this nature is, therefore, not associated with the cancer-pro-
ducing properties of the molecule. More recently Fieser and Putman (1947)
have made an extensive survey of the effect of lead tetra-acetate on hydro-
carbons. They concluded that although some correlation between chemical reac-
tivity and carcinogenic potency is apparent, this correlation is not perfect. The
rate of reaction of the 10-alkyl-1:2-benzanthracenes remained practically the
same, although cancer-producing activity falls off rapidly as the length of chain
increases. Furthermore, the feeblv active 9:10-dimethylanthracene was actually
found to react faster than the potent carcinogen 9:10-dimethyl-1:2-benzanthra-
cene. And finally, the moderately carcinogenic 1:2:5:6-dibenzanthracene does
not react with lead tetra-acetate.
Further evidence as to the reactivity of meso methyl groups was provided
by Badger and Cook (1939), who brominated 9:10-dimethv[-1:2-benzanthracene.
Both methyl groups were attacked, the product being 9:10-bisbromomethyl-1:2-
benzanthracene. Barnett and Matthews (1926) had previously-observed the
same sort of reactivity in 9:10-dimethylanthracene, which they brominated to
9:10-bisbromomethylanthracene. It is of some interest, therefore, that Badger
and Cook (1940) found that 9-methyl-1:2-benzanthracene and 6-methyl-1:2-
benzanthracene are not brominated in the methyl group, but are substituted in
the nucleus to give the corresponding lo-bromo- derivatives. The same paper
also records the facile preparation of 10-bromo-1:2-benzanthracene from the
parent hydrocarbon. It is also noteworthy in this connection that meso-acetyl-
1:2-benzanthracene is converted into meso-trichloroacetyl-1:2-benzanthracene by
treatment with sodium hypochlorite (Dansi and Ferri, 1939).
Many other substitution reactions have been investigated. Benzanthracene
has been chloromethylated to give 10-chloromethyl-1:2-benzanthracene (Badger
and Cook, 1939). 1:2-Benzanthranyl-10-mercaptan has been prepared by allow-
ing benzanthracene to react with sulphur monochloride followed by sodium
sulphide (Wood and Fieser, 1940). Benzanthracene has been nitrated, the
major product being 10-nitro-1:2-benzanthracene (Barnett and Matthews, 1925;
Fieser and Hershberg, 1938c). Benzanthracene reacts with methylformanilide to
give the lo-aldehyde (Fieser and Hartwell, 1938). It has also been thiocyanated
to give both 10-thiocyano-1:2-benzanthracene (57 per cent) and 9-thiocyano-1:2-
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benzanthracene (5 per cent) (Wtood and Fieser, 1941). Benzanthracene has also
been subjected to a variety of Friedel-Crafts reactions. With ethylchloroglyoxa-
late, in nitrobenzene, 1:2-benzanthranyl-10-glyoxylic acid was produced in good
yield (Badger and Cook, 1940). With acetyl chloride in nitrobenzene a meso
acetyl derivative (almost certainly the 10-acetyl-) was produced (Dansi and
Ferri, 1939). With acetic anhydride, however, the reaction was found to be
rather more complex and the products isolated were: mneso-acetyl-, 7-acetyl-,
6-acetvl-, and two acetyl derivatives of unknown orientation (Cook and Hewett,
1933). With oxalvl chloride both the 10-carboxylic acid and 4:10-oxalyl-1:2-
benzanthracene were obtained (Dansi, 1937). Further, by heating benzantnracene
and chloroacetic ester with copper at a high temperature Dansi and Ferri (1939)
obtained some ethyl 1:2-benzanthranyl-10-acetate.
Relatively little work has been carried out on the direct substitution of car-
cinogens other than that already mentioned, and no satisfactory chemical dis-
tinction between carcinogenic and non-carcinogenic hydrocarbons has yet been
discovered. 3:4-Benzpyrene, for example, is very readily thiocyanated to the
5-thiocyano- derivative; but anthracene also reacts readily, to give 9:10-dithio-
cyanoanthracene (Wood and Fieser, 1941), and there is clearly no specificity in
the reaction. The chemical work with this reagent is interesting, however.
10-Methyl-1:2-benzanthracene was found to be substituted in the free 9- position,
to give 9-thiocyano-10-methyl-1:2-benzanthracene; and 9-nmethyl-1:2-benzan-
thracene was found to be substituted in the free 10- position to give the 10-thio-
cyano- derivative. On the other hand, methylcholanthrene was attacked in the
methylene group directly attached to the meso position. It is useful to compare
the actions of lead tetra-acetate, and of bromine, on these hydrocarbons so far
as the work has been carried out.
A few interesting substitution reactions have been carried out with benz-
pyrene. It is readily chlorinated in the 5- position (Windaus and Raichle, 1939),
and it is nitrated to 5-nitro-3:4-benzpyrene (Windaus and Rennhak, 1937;
Fieser and Hershberg, 1939; Eckhardt, 1940b). Windaus and Rennhak have
also described a number of other substitution products, including a tribromo-
derivative and a sulphonic acid. It is interesting that acetylation of benzpyrene
gives mainly the 10-acetyl-derivative (Windaus and Raichle, 1939; Fieser and
Hershberg, 1939). Benzpyrene also reacts readily with methylformanilide to
give the 5-aldehyde (Fieser and Hershberg, 1938c). This reagent reacts niiore
readily with anthracene than with benzanthracene, and the carcinogenic 1:2:5:6-
dibenzanthracene is not attacked even under considerably more drastic conditions.
THE INFLUENCE OF THE SHAPE AND SIZE OF THE MIOLECULE.
It has often been suggested that carcinogenic activity is associated with
certain optimum molecular dimensions, and that the shape and size of the mole-
cule is of paramount importance for the development of carcinogenic activity.
As early as 1935, for example, Barry, Cook, Haslewood, Hewett, Hieger and
Kennaway remarked that their results were " in keeping with the view that there
is an optimum state of molecular complexity for carcinogenic activity." The
hypothesis was not, at first, described at length, but it was clearly the basis for
nmuch of the synthetic work.
Much attention has been paid to the " simplification " of the molecules of
known carcinogens by the replacement of benzene rings with 5-membered rings
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or by one or more alkyl groups. This process led, for example, from 1:2:5:6-
dibenzanthracene to 5:6-cyclopenteno-1:2-benzanthracene, and to 5:6-dimethyl-
1:2-benzanthracene, to 5-methyl- and to 6-methyl-1:2-benzanthracene. All these
compounds were found to be moderately active. In the same way cholanthrene
and methyloholanthrene have been " simplified." 5:10-Dimethyl-1:2-benzan-
thracene (LX) is an extremely active carcinogen, as is cholanthrene (LIX).
1:2-cycloPenteno-5:10-aceanthrene (LXI) is slightly to moderately active. Further
" simplification " to 1:2-dimethyl-5:10-aceanthrene (LXII) to 1:2-cyclopenteno-5-
methylanthracene (LXIII), and to 5:10-aceanthrene (LXIV), however, gives rise
to inactive compounds (Shear, Leiter and Perrault, 1941; Shear, 1938).
LIX. LIX. LXI.
CHd
LXII. ILXIII. LXIV.
Many examples of this type of "simplification" could be quoted, and it was
this which led Hewett (1940) to point out that nearly all the carcinogens are
derivatives ofphenanthrene substituted in two or more ofthe positions i, 2, 3 and
4. Further substitution of 2:3-benzphenanthrene (i.e. 1:2-benzanthracene), for
examnple, in either or both ofthe remaining 1- and 4- positions gives cholanthrene,
3:4-benzpyrene, and 9:10-dimethyl-1:2-benzanthracene, all of which are strongly
carcinogenic. Again, further substitution of 3:4-benzphenanthrene in the remain-
ing 1- or 2- positions also leads to pronounced activity, as in 1:2:3:4-dibenz-
phenanthrene, 1-methyl-3:4-benzphenanthrene, and 2-methyl-3:4-benzphenan-
threne. Again, fiurther substitution of 1:2-benzphenanthrene (i.e. chrysene) in
either or both of the remnaining 3- or 4- positions also leads to carcinogens,
notably 1:2-dimethylchrysene. It is significant that 1:2:3:4-tetramethylphenan-
threne is also slightly carcinogenic.
The hypothesis that the shape and size of the molecule is of paramount
importance was stated at length by Bergmann (1942). He suggested (i) that the
molecule ofacarcinogenacts as awhole, andthat the shape andsizeofthemolecule
deternmine its activity; (ii) that all carcinogens may be conceived as parts
of an ideal " carcinogenic structure; and (iii) that every substance which
imitates more or less closely a given parent structure resembles italso in its cancer-
producing action. In what amounts to an extension of the hypothesis, Lettre
(1944) pointed out that when the polycyclic aromatic hydrocarbons are con-
sidered as derivatives of anthracene and phenanthrene, those which still possess
a plane of symmetry through the centre of the middle ring of the two original
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hydrocarbons are never carcinogenic. According to this author the loss of this
symmetry by substitution is a necessary but not sufficient condition for carcino-
genic activity.
This hypothesis that carcinogenic activity is determined by optimum nmole-
cular dimensions is of considerable interest, and it has several advantages over
any other hypothesis which has so far been announced. On the other hand, it is
by no means completely satisfactory. The heterocyclic analogues and the
fluorene analogues of the carcinogenic hydrocarbons provide considerable support
for the hypothesis, but also many exceptions. It is of considerable interest that
the methyl derivatives of 1:2-benzacridine (3:4-benzacridine in American number-
ing, and 7:8-benzacridine in the French papers) are very active carcinogens, as
might be predicted by analogy with the corresponding benzanthracenes. On the
other hand, the corresponding 3:4-benzacridines (1:2-benzacridines in American
numbering, and 5:6-benzacridines in the French papers) are either inactive or have
only slight activity. Again, 4:9-dimethyl-5:6-benzthiophanthrene (XXXVIII)
has almost the same activity as the corresponding hydrocarbon, 9:10-dimetlivl-
1:2-benzanthracene, either when tested by painting on the skin or by subcutaneous
injection. Yet 4:7-dimethyl-2:3:5:6-dibenzthionaphthene (XLI) is only mocde-
rately active to the skin of mice, and inactive when administered bv injection.
Often quoted in support of the hypothesis that molecular architecture is of
predominant importance in regard to carcinogenic activity is the observation
of Dodds, Lawson and Williams (1941) that a-ethyl-3-sec-butylstilbene has pro-
duced cancers in mice. This hydrocarbon (LXV) is, of course, an " open model "
of3:4-benzpyrene. Too much weight should not be given to this isolated example,
X/
LXV.
however, for ethyl8ecbutylstilbene produced only 2 tumours in 100 mice, and in
view of this very low order of carcinogenicity and to the known impossibility
of avoiding occasional contamination (Earle, 1943; Hieger, 1946; Andersoi,
1947), the significance of the observation must remain in some question. Ben-
zanthracene itself has produced 1 tumour in 80 mice, and this hydrocarbon is
almost invariably quoted as being non-carcinogenic.
In spite of much evidence which tends to support the view that the shape and
size of the molecule governs the activity, it is difficult to believe that molecular
architecture alone is the governing factor. It is noteworthy that activity is to be
found in compounds as simple as 9:10-dimethylanthracene and 1:2:3:4-tetra-
methylphenanthrene and as large and complex as 1:2:3:4-dibenzpyrene and 3:4:8:9-
dibenzpyrene, while many compounds of intermediate complexity are completely
devoid of activity.
Some interesting experiments by Lacassagne and his co-workers may have
some significance in this connection (Lacassagne, Buu-Hoi and Cagniant, 1944;
Lacassagne, Buu-Hoi and Rudali, 1945 ; Lacassagne, Buu-Hoi, Daudeland Ruda.li,
1944). These workers made repeated application to the skin of mice with solu-
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tions containing a mixture of two hydrocarbons of sinmilar molecular configuratioii,
but one of which is weakly carcinogenic (or inactive) and the other strongly car-
cinogenic. The pairs of compounds were: 1:2:5:6-dibenzacridine and 1:2:5:6-
dibenzanthracene; chrysene and methylcholanthrene; 1:2:5:6-dibenzfluorene
and methylcholanthrene. Tumours were produced more slowly in eachl case than
when the potent hydrocarbon alone, at the same concentration, was applied.
Lacassagne supposes that the two substances, having the same affinity because
of their analogy of structure, penetrate into the same cells, where they are fixed
in the same substrate. Each mtolecule of the weakly active substance, by fixing
itself in the cell, hinders the fixation of the molecule of potent carcinogen, and
thus delays the appearance of tumours. The interesting feature of this work is
that although the weakly active substances can hinder the rapid production of
tumours, presumably by " blocking "' the ' receptors," they still lack the total
requirements for rapid carcinogenic activ-ity. It seems likely, therefore, that
some feature in addition to the optimum mnolecular d,nensions is necessary for
the development of potent carcinogenic activity.
THE IMPORTANCE OF THE K POSITION.
It has long been recognized that most of the carcinogens of the polycyclic
aromatic type are derivatives ofphenanthrene, although all derivatives ofphenan-
threne are not carcinogenic. In an attempt to determine whether the phenan-
threne ring system is essential, 9:10-dimethylanthracene and 1:2:3:4-tetramethyl
phenanthrene were submitted to extensive tests (Badger, Cook, Hewett, Kenna-
way, Kennaway and Mlartin, 1942; Kennawav, Kennaway and Warren, 1942).
Both compounds are closely related to the potent carcinogen 9::10-dimethyl-1:2-
benzanthracene. Both compounds were found to be slightlv active, and it cani
only be concluded therefore that while phenanthrene is a cominon component
of carcinogens of this type it is not absolutely essential.
In spite of this result, evidence has continued to accumnulate that the phenan-
threne ring system is of special significance. Robinson (1946) has suggested that
an activated phenanthrene-type bridge is implicated in mnost carinogens, and
there is considerable evidence in favour of this hypothesis. The hydrogenation
of the phenanthrene-type bridge in methyleholanthrene, for example, gives
6:7-dihvdro-20-methylcholanthrene, which is devoid of activity; although it
mnust be admitted that this result is inconclusive in view ofthe somewhat uncertain
effect of hydrogenation on carcinogenic activity (p. 331). The results obtained
with certain sulphur analogues of 9:10-dimethyl- 1:2-benzanthracene (p. 329)
are also inconclusive, bitt also provide some support for the hypothesis. Again,
it is of considerable interest that although 1:2:3:4-dibenzphenanthrene is a potent
carcinogen, the 9- and 10- methvl derivatives of this compound are inactive
(Badger, Cook, Hewett, Kennaway, Kennaway, Martin and Robinson, 1940;
Harris and Bradsher, 1946). This suggests that the phenanthrene double bond
inust be unsubstituted, and that the presence of the methvl group offers some
sort of " interference." It is, perhaps, unfortunate that these results have not
been confirmed by the skin-painting technique as well as by subcutaneous injec-
tion. In any case, a similar relationship does not seem to hold with the 3- and
4-methyl-1:2-benzanthracenes, which are both moderately active by injection,
although only feebly so by application to the skin. Furthermore, 7-methyl-1:2:3:4-
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dibenzpyrene, like the parent hydrocarbon, is a potent carcinogen, and the
phenanthrene double bond is again substituted.
In a further approach to the problem, Pullman (1947a, b, c, -d), and Pullman
and Pullman (1946a, b), have developed a theory relating carcinogenic activity
with an optimum density of 7r electrons on the phenanthrene-type double bond,
or the K position as it has been called. A method for the calculation of such
electronic charges has been worked out. This method is based on the resonance
theory by which benzene is considered to be a hybrid of the structures
A. B. C. D. E.
Summing the electronic charges required for each ofthese structures and calculat-
ing that the Dewar forms (C, D and E) contribute 22 per cent to the benzene
hybrid and the Kekule forms (A and B) the remnaining 78 per cent, Pullman was
able to draw a molecular diagram showing the distribution of the Tr electrorns.
The calculations for tetracyclic molecules are complex, but many of these struc-
tures have now been worked out. Methyl groups act as slight donors ofelectrons
to a ring system, and it is the essence of the Pullman theory that this increase
in electronic charge converts an inactive structure (such as benzanthracene) into
a carcinogen. Pullman has calculated the electronic charge of the K position
for many methyl derivatives of benzanthracene, of benzphenanthrene, of 1:2-
benzacridine and of 3:4-benzacridine (Table IX). The effect of a methyl group
on the K position was found to vary considerably, depending on the position of
the methyl group. The meso positions in benzanthracene, for example, were
found to have the most pronounced effect, and the effect ofmore than one methyl
group is additive. The critical charge on the double bond, below which the
compounds are not carcinogenic, was found to be about 1-29e. At first sight the
correlation between the electronic charge and the carcinogenic activity is ex-
tremely good-in fact rather too good, considering the uncertain nature of the
approximations required in the theoretical treatment. When set out as in Table
IX, however, where all the compounds have been arranged irn order of increasing
charge, together with assessments of activity towards skin of mice and to sub-
cutaneous tissue, certain irregularities become apparent; the benzphenan-
threnes are especially evident, for example. lFurthermore, the evidence for the
upper limit to the optimum electronic charge is rather slender.
Clar (1941) has examined the absorption spectra of many polycyclic aromatic
hydrocarbons, and has deduced interesting relationships between structure,
reactivity and the wave lengths of the absorption bands. He associates certain
bands with the " Dewar " forms of the hydrocarbons, and other bands with the
" Kekule " forms. Some evidence is presented that the shift in wave length
(towards longer wave length) by the linear or angular addition of benzene rings,
etc., can be correlated with the colour of the hydrocarbon and its " reactivity."
If this correlation is valid it should be possible to compare the wave length of
the appropriate absorption band with the electronic charge as obtained by Pull-
man, and with the carcinogenic activity. In benzanthracene, for example,
Clar associates the absorption bands of the Kekul6 form with the bond which
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Pullman calls the K position. It is ofinterest, therefore, that Jones (1940, 1943)
has found a limited correlation between the wave length of this absorption band
andthe carcinogenic activity. In the limited series ofthe methylbenzanthracenes
the correlation is quite good; but the correlation cannot be extended to other
hydrocarbons, and, indeed, breaks down with the alkylbenzanthracenes other
than the methyl derivatives. In this connection it may be mentioned that there
is no correlation to be found between the wave length of the fluorescence bands
and carcinogenic activity. Nor is there any correlation between carcinogenic
activity and the intensity of fluorescence (Bruce, 1941; Bruce and Todd, 1939;
Hieger, 1930; Berenblum and Schoental, 19406a).
In view of the very extensive calculations which would be required Pullman
did not calculate the electronic charge for representative pentacyclic hydrocar-
bons; but on general grounds these compounds were considered to support the
theor'Y. It is not difficult, for example, to understand-on the basis of this
theory--why 1:2:3:4-dibenzanthracene is not carcinogenic, why 1:2:7:8-dibenzan-
thracene is only very feebly carcinogenic, and 1:2:5:6-dibenzanthracene is
moderately active. Furthermore, the theory also provides a reasonable explana-
tion for the relatively feeble activity of 9:10-dimethyl-1:2:5:6-dibenzanthracene;
it is only necessary to assume that the electronic charge is above the optimum by
virtue of the two meso methyl groups in addition to the benz- rings. On the
other hand, 9-methyl-1:2:5:6-dibenzanthracene must have a somewhat lower
charge (nearer the optimum) and is strongly carcinogenic. Similarly, it is also
understandable why 9:10-dimethyl-1:2:7:8-dibenzanthracene is strongly carcino-
genic and 9:10-dimethyl-1:2:3:4-dibenzanthracene is inactive. Again, the effect
of the meso nitrogen atom, as in 1:2:5:6-dibenzacridine, may be to reduce the
charge on the K position and hence the carcinogenic activity. The effect of
two nitrogen atoms, as in 1:2:5:6-dibenzphenazine, will be greater, and this
compound is inactive.
In a further paper Pullman (1947c) has attempted to explain the observation
that while 5:6-cyclopenteno-1:2-benzanthracene is a moderately active carcinogen,
6:7-cyclopenteno-1:2-benzanthracene is only feebly active. It was suggested that
by virtue of the Mills-Nixon effect the two structures (LXVI) and (LXVII) pre-
dominate for these compounds, owing to the " bond fixation imposed by the
''f/V//X /\J , /\
LXVI. LXVII.
five membered rings. For this reason Pullman suggests that the charge on the
K region is very much greater in the case of the 5:6 compound than in the 6:7
derivative. On the other hand, it must be remembered that 5:6-dimethyl-1:2-
benzanthracene i8 potent, and that 6:7-dimethyl-1:2-benzanthracene is only very
slightly active (Barry, Cook, Haslewood, Hewett, Hieger and Kennaway, 1935).
Furthermore, 1:2:5:6-dibenzanthracene is a moderate carcinogen, while 1:2:6:7-
dibenzanthracene is inactive (Barry et al., 1935). It is therefore possible that
the effect is due as much to the position ofsubstitution as to any " bond fixation,"
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In any case, the 6:7 derivative has many other structures which allow for the
Mills-Nixon effect than that represented in (LXVII).
A further examination of the Pullman theory reveals many important excep-
tions. One would expect the methylbenzanthracenes with methyl groups in the
angular ring to be active, yet all these compounds are inactive or have only trace
activity. The inactive compounds of this type (all of which must be considered
as exceptions) include 1'-methyl-, 2'-methyl-, 3'-methyl-, 4'-methyl-, 1':10-di-
methyl-, 2':6-dimethyl-, 2':7-dimethyl-, 3':6-dimethyl- and 3':7-dimethyl-1:2-
benzanthracenes. It is also surprising thatacenaphthanthracene is onlyslightly
active, and that 3:9-dimethyl- and.5:8-dimethyl-1:2-benzanthracenes are inactive
and that 7-methyl-8:9-ace-1:2-benzanthracene is inactive.
Again, as has been detailed in p. 324, a study of 10-substituted 1:2-benzan-
thracenes has shown conclusively that both electron-attracting and electron-
repelling groups can convert an inactive parent hydrocarbon, such as benzan-
thracene, into a cancer-producing derivative. It is interesting to compare the
effect of a methyl group with that of the cyano group, for example. 10-Methyl-
1:2-benzanthracene and 9:10-dimethyl-1:2-benzanthracene are potent car-
cinogens. 10-Cyano-1:2-benzanthracene is only slightly active, but 9-methyl-10-
cyano-1:2-benzanthracene is a particularly potent compound.
In spite of these exceptions, the Pullman theory has much to commend it as
a basis for further work. The charge of7r electrons is directly associated with
" reactivity," and Badger (1948) has therefore attempted to examine the validity
of the calculations by an experimental method. Osmium tetroxide is known to
add to the K position of many carcinogenic and related compounds (Cook and
Schoental, 1947), and a method formeasuring the rate ofaddition has been devised
(Badger, 1948; Badger andReed, 1948). Using this method the rate of addition
of osmium tetroxide to 18 carcinogenic and related non-carcinogenic hydro-
carbons and derivatives has heen
,tudied. Most of these compounds were
derivatives of benzanthracene, but other representative carcinogens were also
included. Other things being equal, osmium tetroxide should add more rapidly
to those compounds with the greater charge on the K position. In agreement
with Pullman it was found that methyl groups, especially in "favourable"
positions, have a pronounced effect on the rate of reaction, and hence, pre-
sumably, on the charge at the K position. 9:10-Dimethyl-1:2-benzanthracene
and other meso substituted benzanthracenes were found to react very much
faster than benzanthracene itself, although compounds with methyl groups sub-
stituted at positions far from the K position showed only a very slight increase
inreactivity. On the other hand, osmium tetroxide was found to react rapidly
with both acenaphthanthracene and with 2':7-dimethyl-1:2-benzanthracene.
Indeed, the veryslightly carcinogenic acenaphthanthracene reacted at about the
same rate as cholanthrene-a very potent carcinogen. Furthermore, 2':7-di-
methyl-1:2-benzanthracene, which is inactive, reacted at about the same rate as
1:2-dimethylchrysene, which is a moderately potent carcinogen. These two
compounds, acenaphthanthracene and 2':7-dimethyl-1:2-benzanthracene, are,
however, also exceptions to the Pullman theory, and the agreement is therefore
quite good. It was also found, however, that derivatives of 3:4-benzphenan-
threne reacted very much slower than benzanthracene, which is unexpected from
the figures quoted in support of the theory by Pullman. Furthermore, phenan-
threne itself reacted very much slower than benzanthracene, which is not the
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TAI3LE IX.-Density of 7r Electrons at K Position and Carcinogenic Activity.
Compound.
Naphthacene
Anthracene
Triphenylene .
3:4-Benzacridine
1:2-Benzacridine
Chrysene
5-Methyl-3:4-benzacridine
Naphthalene
1:2-Benzanthracene
5:8-Dimethyl-3:4-benzacridine
5:7-Dimethyl-3:4-benzacridine
5:9-Dimethyl-3:4-benzacridine
Phenanthrene
8-Methyl-1:2-benzanthracene
5-Methyl-1:2-benzacridine
3:4-Benzphenanthrene
7-Methyl-1:2-benzanthracene
6-Methyl-1:2-benzanthracene
9-Methvl-1:2-benzanthracene
5-Methyl-1:2-benzanthracene
3-Methyl-1 2-benzanthracene
4-Methyl-1:2-benzanthracene
5:7:9-Trimethyl-3:4-benzacridine
5:9-Dimethyl-1:2-benzacridine
5:8-Dimethyl-1:2-benzacridine
5:7-Dimethyl-1:2-benzacridine
10-Methyl-1:2-benzanthracene
5:6-Dimethyl-1:2-benzanthracene
5:9-Dimethyl-1:2-benzantbracene
8-Methyl-3:4-benzphenanthrene
6-Methyl-3:4-benzplhenanthrene
4:9-Dimethyl-1:2-benzanthracene
I-Methyl-3:4-benzphenanthrene
2-Methyl-3:4-benzphenanthrene
5:7:9-Trimethvl-1:2-benzacridine
7-Methyl-3:4-benzphenanthrene
5:10-Dimethyl-1 :2-benzanthracene
9:10-Dimethyl-1 :2-benzanthracene
4:10-Dimethyl-1:2-benzanthracene
6:9:10-Trimethyl-benzanthracene
5:9:10-Trimethyl-benzanthracene.
5:6:9:10-Tetramethylbenzanthracene
Density of 7r
electrons at K
position (Pullmnan).
e.
1 i 258
1 -259
1-i260
1 260
1 - 270
1*272
I*273
1-274
1*283
1-284
1*i285
1 i286
1*i291
I1-292
I 293
. 1 293 (1.293).
1*294
1*294
1 i 296
1*296
1 - 298
1 298
1 i298
1*302
1*i304
1 i 304
1*i306
1*307
1*i309.
. 1 309 (1i 305)
1 310(1 302)
1*311
. 1 312 (1. 308)
. 1 312 (1*308)
1*312
. 1-313(1,304)
1*317
1*319
1*i321
1*i330
1*332
1*343
Carcinogenic activity.
Skin. Subcutaneous
tissue.
0
O . 0
0
0
0
O . 0
0
0
O . 0 ± . 0
0
0 . +
0
-7 ~~0
+ . 0
+ . +
+ . +
++
++ . 4
+ . O
+ * +
-4- ~0
++±+. .1
4++ * ++
++ * ++
4--+ 4*T' ++
++[++.
++++
- .
W+ . O
. +++-
+ . 0+
+-F-F- * ±+
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result expected fromn the Pullman calculations. Recentlv, however, Berthier,
Coulson, Greenwood and Pullman (1948) have calculated the bond orders for the
tetracyclic aromatic hydrocarbons by the method of molecular orbitals. These
calculations are in better agreement with the kinetic experiments with osmium
tetroxide in that 3:4-benzphenanthrene is given a lower bond order than benzan-
thracene; but this is an observation which casts further doubt on the validity
of the correlation as observed by Pullman.
It is also noteworthy that Badger found that 10-cyano-1:2-benzanthracene
reacted very much slower than benzanthracene, and that the potent carcinogen
9-methyl-10-cyano-1:2-benzanthracene reacted slightly slower than the inactive
benzanthracene. This is in agreement with general electronic theory, but
not with the Pullman theory relating carcinogenic activity with the electronic
charge on the K position.
It is of some interest to compare these results with those of Ecklhardt (1940a),
who examined the rate of oxidation of several polycyclic derivatives with per-
benzoic acid. The site ofoxidation is not known, but it is probably the K position.
Eckhardt observed an increase in the rate ofreaction following the introdulction
of a methyl group, and a decrease following the introduction of deactivating
groups, such as -CHO and -N(2. Here again, however, no complete correla-
tion between reactivity and carcinogenic activity was observed.
It can only be concluded, therefore, that no single theory yet advanced satis-
factorily accounts for the carcinogenic activity of all the polycyclic aromiatic
hydrocarbons and their derivatives. The hypothesis that the shape and size of
the molecule governs the activity seems partly true, but will not account for
many observations. Similarly, the Pullman theory, while accounting almnost
quantitatively for the effect of methyl groups on inactive parent hydrocarbons,
fails to account for the many exceptions. It is possible that there is an element
of truth in both theories, and this mnay be supported by the fact that the
exceptions to the one theory seem to be moderatelv well " explained " by the
other. It may be that the carcinogenic hydrocarbons interact with some tissue
component to form a " complex," and that the ease offormation and the stability
of this complex is governed by (a) the molecular dimensions of the molecule, and
(b) the charge of r electrons at one or more of the double bonds. particularly the
K position. The shape and size of the molecule can be conceived as assisting in
the formation of the complex by providing the best " fit " with the specific
cellular receptors. In view of the pronounced aromatic character of all the
carcinogens of the polycyclic type, it seems likely that the forces which bind the
hydrocarbon to the tissue component are the same as those which bind these
substances to polynitro compounds, to antimony pentachloride, stannic chloride,
etc. It must not be expected, however, that there is any correlation between
carcinogenic activity and ability (or even enhanced ability) to form complexes
with such simple components. It must be admitted, however, that the intro-
duction of a methyl group enhances the stabilitv of the resulting picrate, and
also deepens its colour. Furthermore, deactivating groups depress the stability
of picrates, and such complexes as are formed are mostly lighter in colour. Most
of the potent carcinogens form very dark red or purple picrates, a. circumstance
which is clearly related to their aromatic character, but which is not necessarilv
correlated with ability to produce cancers. Unfortunately, very little is known
of these forces (Weiss, 1942). In any case, the complete elucidation of the
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problem of the relationship between chemical structure and carcinogeniic
activity must be left to further investigation.
SUMMARY.
1. Certain tricyclic, tetracyclic, pentacyclic and hexacyclic aromatic hydro-
carbons ortheir homologues are cancer-producing. Most ofthe active compounds,
but not all, are derivatives of phenanthrene.
2. Many closely related heterocyclic compounds are also cancer-producing.
So are certain dibenzfluorenes.
3. The introduction of methyl groups into benzanthracene, benzphenanthrene
and chrysene normally leads to enhanced activity. Two methyl groups, or more,
normally act additively. On the other hand, there seems to be a limit beyond
which the introduction of further methyl groups does not lead to enhanced
activity. The introduction of methvl groups into the angular ring of benzan-
thracene does not have this effect, and all such compounds are either inactive
or have only trace activity.
4. Similar relationships hold for the benzacridines, except that the 1:2-
benzacridines are potentially much more carcinogenic than the 3:4-benzacridines.
5. The introduction of methyl groups into benzpyrene and dibenzanthracene
is more complex. In many cases the effect is to diminish the activity, although
examples of the opposite effect are also known.
6. Alkyl groups other than methyl are progressively less effective as th'e
number of carbon atoms iln the chain increases.
7. Many other substituents in " favourable " positions can convert an inactive
parent hydrocarbon into a cancer-producing derivative. Both electron-attracting
and electron-repelling substituents may have this property. The "favourable "
positions for methyl substitution are not necessarily the same as the "favourable".
positions for other substituents.
8. Partial hydrogenation of a carcinogenic compound sometimes, but not
always, deactivates the substance.
9. The carcinogenic substances are--so far as is known active as such and
are metabolized to inactive derivatives.
10. The carc-inogenic and related non-carcinogenic hydrocarbons are meta-
bolized by the same mechanism, namely, hydroxylation or perhydroxylation.
This oxidation takes place at centres other than those normally attacked by
chemical oxidizing agents.
11. There is no correlation between chemical " reactivity " and carcinogenic
activity.
12. Attempts to relate carcinogenic activity (a) with the shape and size of
the molecule, and (b) with the electronic charge on the phenanthrene-type double
bond present in most carcinogens, have been only partly successful.
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